TW201138631A - Pesticidal mixtures comprising isoxazoline derivatives - Google Patents

Abstract

The present invention relates to pesticidal mixtures comprising a component A and a component B, wherein component A is a compound of formula I wherein A1, A2, Y1, Y2, R1, R2, R3, R4 and R5 are as defined in claim 1, and component B is a fungicide as defined in claim 1. The present invention also relates to methods of using said mixtures for the control of plant pests.

Description

4 4201138631 VI. Description of the Invention: TECHNICAL FIELD OF THE INVENTION The present invention relates to a mixture of abatement active ingredients and a method of using the mixture in the agricultural field. [Prior Art] WO 2009/080250 discloses certain isoxazole compounds having insecticidal activity. SUMMARY OF THE INVENTION The present invention provides a detoxification mixture comprising component A and component B, wherein component A is a compound of formula I

Wherein one of Y1 and Y2 is S, SO or S02 and the other is CH2; L is a direct bond or a fluorene group; A1 and A2 are CH, or one of A1 and A2 is CH and the other is N; R1 Hydrogen or methyl; R2 is a difluoroindolyl or trifluoroindolyl group; R 3 is a 3,5-di>odor-phenyl group, 3,5-di-gas-based, 3,4-di-mouse- Ben 4 201138631 « Base, or 3,4,5-trichloro-phenyl; R4 methyl; R5 hydrogen; or R4 and R5 together form a bridged ruthenium, a 3-butadiene group; A fungicide selected from the group consisting of: strobilurin fungicides comprising groups selected from the group consisting of: Azoxystrobin, Dimoxystrobin, enestrobin (Enestrobin), Fluoxastrobin, Kresoxim-methyl, Metominostrobin, 〇rysastrobin, Picoxystrobin, Baikemin ( Pyraci〇str〇bin) and trifloxystrobin; azole fungicides, including those selected from the group consisting of: Azaconazole, Bromuconazole, ring Cyproconazole, Difenoconazole, Diniconazole, Dakli-M, Epoxiconazole, Fenbuconazole, Fluquinconazole, Flusilazole ), Flutriafol, Hexaconazole, Imazalil, Imibenconazole, Ipconazole, Metconazole, Myclobutanil, IMM (Oxpoconazole), Pefurazoate, Penconazole, Prochloraz, Proclonazole 2011, Prothioconazole, and Shi Xia. Simeconazole, Tebuconazole, Tetraconazole, Triadimefon, Triadimenol, Triflumizole, Triticonazole, Diclobutrazole ), Etaconazole, Furconazole, Thiabendazole and quinconaz〇ie; Phenylpyrrole fungicides, including their choice Free group consisting of: Fenpiclonil and Fludioxonil; Anilino-pain-prepared fungicides, including the group consisting of the following components: Cyprodinil Mepanipyrim H〇t^Pyrimethanil; Morpholine fungicides, which contain them selected from the group consisting of: Aldimorph, Dodemorph, Fenpropimorph ) 'Tridemorph, benzene rust, Fenpropidin and Spiroxamine; methotrexate fungicides, which comprise groups selected from the group consisting of: Isopyrazam , Sedaxane, Bixafen, 0 ratio, Penthiopyrad, Fluxapyroxad, Boscalid, penflufen, Fluoride, Fluopyram, II compound 201138631

Compound of formula III

(III), and compound of formula IV

Carboxamide hydrochloride fungicides comprising groups selected from the group consisting of Mandipropamid, Benthiavalicarb, and Dimethomorph; tetraisophthalonitrile (Chlorothalonil), Fluazinam, Dithianon, Metrafenone, Tricyclazole, Mefenoxam, Metalaxyl, Araraic acid Acibenzolar, Mancozeb, Ametoctradine, and Cyflufenamid ° Formula I compounds have conventional insecticidal activity, while Component B combines 201138631 with Fungicidal activity is conventional. A mixture of two active ingredients of a hydrazine compound and a fungicide enhances the range of action with respect to controlled pests such as animal pests and/or fungal pests. For example, a combination of A and B may result in an increase in the insecticidal action of component A and/or an increase in the effect of component b on the fungus, which may be expected when individual components are used alone. - Aspects This allows the range of pests that can be controlled to expand substantially, and the other side, which increases safety in use through lower application rates. However, in addition to the actual synergy with respect to pest control, the pesticidal mixture of the present invention may have further advantageous properties, which in a broader sense may also be described as a synergistic activity. Examples of such advantageous properties that may be mentioned are: an increase in the range of activity; a reduction in the rate of application of the active ingredient; adequate control of the pest with the aid of the mixture of the invention, sometimes even in the case of individual compounds as a whole. Beneficial behavior during formulation and/or application, such as in grinding, screening, liturgy, dissolution or dispersion; enhanced storage stability; improved photostability; more favorable degradation; improved toxicology And/or biotoxicological behavior; improved characteristics of useful plants, including: germination, crop yield, more developed root system, increased tillering, increased plant height, larger leaves, less dead base leaves, enhanced tillers, more green leaves Color, requires less fertilizer, requires less seeds, more productive sub-drugs, early opening & early maturity, less plant verse (falling), increased shoot growth, increased plant vigor and early Germination; or any other advantage known to those of ordinary skill in the art to which the invention pertains. 201138631 雩 [Embodiment] The compound of the formula I and its preparation method are known from WO 2009/080250. Component B is a well-known person and has the following CAS numbers: Azoxystrobin (13l860-33-8), Dimoxystrobin (149961-52-4) Enestrobin (Enestrobin) 23 8410-1 1-2), Fluoxastrobin (l 93 740-76-0), Keshenxin (methyl) (143390-89-0), Metominostrobin ( 13 340 8-50-1) , orysastrobin ( or ysastrobin) (248593-16-0), picoxystrobin (1 17428-22-5), and pyraclostrobin (1 750) 1 3 -1 8-0) > Trifloxystrobin ( 141517-21-7), Azaconazole (60207-3 1-0) > Bromuconazole (l 16255-48-2), Cyproconazole (94361-06-5) Difenoconazole (1 19446-68-3), Diniconazole (8365 7-24-3) Dakley ( Diniconazole-M) (83657-18-5) Epoxiconazole (l3385-98-8) Fenbuconazole (1 14369-43-6), Fluquinconazole (13 6426) -5 4-5) , Guardian (Flusilaz Ole) (85 509-19-9), Fractal (Flutriafol) (76674-21-0), Fickley 201138631 (Hexaconazole) (79983-71-4), Imazalil (58594-72- 2), Imibenconazole (86598-92-7), Ipconazole (l 25225-28-7), Metconazole (125 1 16-23-6), Mike Myclobutanil (8867 1-89-0), Oxpoconazole (174212-12-5), Pefurazoate (5 801 1-68-0), Penconazole ) (66246-88-6), Poker Pull (Prochl or az) (67747-09-5), Propiconazole (60207-90-1), Prothioconazole (178928-70- 6), Shimeconazole (149508-90-7), Tebuconazole (107534-96-3), Tetraconazole (l 12281-77-3), and three-point (Triadimefon) ) (43 121-43-3), Triadimenol (5 521 9-65-3), Triflumizole (993 87-89-0), Sterilization 0 (Triticonazole) (l 3 1983) -72-7), Diclobutrazol (7 673 8-62-0) 'B ring mouth Sitting (Etaconazole) (60207-93-4), Fluconazole (86386-73-4), Fluconazole-cis (1 12839-32-4), and rot (Thiabendazole) )(148-79-8) '啥康. Sit (103970-75-8), Fenpiclonil (74738-17-3), Guardian Ning 201138631 (Fludioxonil) (l 3 1 341-86-1), Cyprodinil (l 215 52-61-2), Mepanipyrim (l 10235-47-7), Pyrimethanil (53 1 12-28-0), Adimorpholine (Aldim or ph) (91315-15 -0), Dodemorph (1593-77-7), Fenpropimorph (67564-91-4), Trid or ph (81412-43-3), benzene rust Fenpropidin (67306-00-7), Spiroxamine (l 18134-30-8), Isopyrazam (881685-5 8-1), Sedaxane ) (874967-67-6), Bixafen (581809-46-3), D-Benthiopyrad (183675-82-3) Fluxapyroxad (907204- 3 1-3), Bosclid (1 88425-85-6), Penflufen (494793-67-8), Fluorine. Fluopyram (658066-35-4), diacetylergic acid (dipropionamide) (374726-62-2), Benthiavalicarb (413615-35-7), Dimethomorph (l 10488-70-5), tetra-isophthalonitrile (four gases: isophthalonitrile) (1897-45-6), and sulphate (Fluazinam) (79622-59-6), 1 Dithianon (3347-22-6) > Metrafenone (220899-03-6) % Tricyclazole (418 14-78-2), 右灭达(Mefenoxam) (70630-17-0) Gatorade 201138631 (Metalaxyl) (57837-19-1), aric acid benzene (Acibenzolar) (126448-41-7) (aralic acid benzene-S-methyl ( 126448-41-7)), Mancozeb (801 8-0 1 - 7), Ametoctradine (865318-97-4), Cyflunicinum (Cyfliifenamid) (180409- 60-3) and Kresoxim-methyl (143390-89-0). Compounds of formula II are known from WO 2008/053044, compounds of formula III are known from WO 2007/048556, and compounds of formula iv are known from WO 2010/000612. ▼〆7. 0 涵: work / enlistment, Shijian derivatives, such as ester derivatives. In particular, the reference arsenic benzene includes a reference, and is preferably a phenyl s-methyl group. The combination of the present invention may also include the active ingredient B of the above-mentioned IV u α, or the mouth knife, if, for example, it is desired to expand the pest. The scope of biological control. For example, agriculture == or three groups... any compound of formula 1 or mixed with any preferred member of Lbtr is advantageous. In addition to the components, the mixture of the invention may also include the specific examples thereof, and the present invention may include only the active components of the component pests as the k-component in other winter inventions. A kind of known pests Y-series S and Y2-series CH2. γ is SO and γ2 is Cll2. 'Y1 is S〇2 and γ2 is ch2. In a group of preferred compounds of the formula, in another group of preferred compounds of formula I, the other formula is better! In another group of preferred compounds of the formula, γ2 is S and γ is CJH2. 12 201138631 2 : _, and a preferred compound of the formula 1 wherein the Y 2 system is so and the y 1 is ch 2 . CH2. - (iv) Among the compounds of formula 1 which are excellent, Y2 is s〇2 and y] is a base; y is: in a preferred compound of formula 1, L is a direct bond or a methylene "hydrogen or a:=n;rcr2; Ai and A2 are ch; r4 is methyl; and han, hydrogen y dichloro-phenyl; in the compound of formula 1 on the basis of Ci, '" direct bond or methylene

Rl m is cut into -S0 and the other is CH2; V and V are C_H; 4 = methyl; R, tri (4); R3 is 3 R is a fluorenyl; and R5 is hydrogen. Base 2 - middle Γ: In the compound of formula 1, direct bond or Aaru R. # . . w system s〇2 and another line CH2; V and A2 system C_H; system is a phenyl group R3 series phenyl; I, and R5 is hydrogen. In the preferred compound of formula 1, L is a direct bond or hydrazine, Y and Y2 are one of R. # φ 糸s and another is ch2; Αι and Α2 are C_H; wind or methyl; And R.4 is a methyl group of 4 groups and a gas group, which together form a bridged 1,3-butadiene group. Y is in another group of preferred hydrazine compounds, "one of the direct bonds R = Y (10) and another, 2; ... is CH; R is 虱 or 曱; R2 = and 4 - gas a group, R is 3,5-dichloro-phenyl; /, and R and R5_ form a bridged 1'3-butadiene group. In another group of preferred compounds of formula 1, L is a direct bond or Methylene 13 201138631 base; one of Y1 and Y2 is S02 and the other is CH2; A1 and A2 are CH; R1 is hydrogen or sulfhydryl; R2 is trifluoromethyl; R3 is 3,5-digas-benzene And R4 is a fluorenyl group; and R4 and R5 together form a bridged 1,3-butadiene group. In yet another preferred group of compounds of formula I, L is a direct bond or an anthracene group; Y1 and One of Y2 is S and the other is CH2; A1 is CH; A2 is N; R1 is hydrogen or sulfhydryl; R2 is trifluoromethyl; R3 is 3,5-digas; phenyl; And R5 is hydrogen. In yet another preferred group of compounds of formula I, L is a direct bond or a methylene group; one of Y1 and Y2 is SO and the other is CH2; A1 is CH; A2 is N; R1 is hydrogen or fluorenyl; R2 is trifluoromethyl; R3 is 3,5-dichloro-phenyl; R4 is fluorenyl; and R5 is hydrogen. In yet another preferred group of compounds of formula I, L Straight Bond or methylene; one of Y1 and Y2 is S02 and the other is CH2; A1 is CH; A2 is N; R1 is hydrogen or sulfhydryl; R2 is trifluoromethyl; R3 is 3,5- Gas-phenyl; R4 is a fluorenyl; and R5 is hydrogen. In yet another preferred group of compounds of formula I, L is a direct bond; Y1 is S, SO or S02; Y2 is CH2; A1 is CH; A2 is CH; R1 is hydrogen; R2 is trifluoromethyl; R3 is 3,5-digas-phenyl; R4 is methyl; and R5 is hydrogen. In yet another preferred group of compounds of formula I, L series direct bond; Y1 is S, SO or S02; Y2 is CH2; A1 is CH; A2 is CH; R1 is sulfhydryl; R2 is trifluoromethyl; R3 is 3,5-digas-phenyl; In another group of preferred compounds of formula I, L is an anthracene group; Y1 14 201138631 is CH2; γ2仫1糸s, SO or S02; Α1 is a CH; Α2 system CH; R1 is hydrogen; R2 is -#7, ~fluoromethyl; R3 is 3,5-dichloro-phenyl; R4 is fluorenyl; and R is hydrogen. In addition, the preferred formula I Among the compounds, L is an anthracene group; γ1 is a CH2; γ2 is a 1糸S, SO or S02; a lanthanide CH; a Α2 system CH; an R1 system ruthenium; 1糸 difluoroantimony; R3 is 3,5-di-gas-phenyl; R4 is methyl; and R5 is hydrogen-crossing. 'When L-line direct bond, Y2 system CH2 and Y1 system s, SO or S02 and when τ and ·, - are an anthracene group, Y2 is S, SO or S02 and Y1 is CH2. *^1*^ .丨 ILJ Another alternative to the selection of compounds Each of the compound groups is taken in conjunction with any of the substituent definitions in any other preferred compound group. The compound of formula I includes at least one palm center and may be present as a compound of formula γ or a compound of formula I*.

(η Formula I"The compound is more biologically active than the compound (confirmed by X-ray analysis). The composition Α can be 1* and the compound can be in any ratio. 15 201138631

For example, a mixture of (10) to 99:1 molar ratio, for example, 1 〇: 1 to 1:1 〇 molar ratio, :: 5 〇: 5 〇 molar ratio. Preferably, component A is a racemic mixture of a compound and a compound of formula I**. j. Shita component A is a mixture of I** and a mixture of I**, P* The Momo ratio is, for example, greater than 50%, such as $ s to v 55 , 60 , 65 , 70 , 75 , 80 , 85 , 90 , 95 , 96 97 ' 98 , or At least 99%. Preferred compounds of formula I are shown in the table below. Table A · Compounds of the formula 5 (la)

(la) Compound number indicates the position of the center of the palm. The stereochemistry of * is a racemic mixture.

L key R1 Y· Y2 CH,

S CH,

3_ T T racemic mixture racemic mixture racemic mixture key bond ch3 ch3 so(cis) so(trans) 7_ racemic mixture racemic mixture

Ch3 Η S〇2 ch2 ch2ΈηΓ ~ch7 racemic mixture

H

H so(cis) S0(i^y racemic mixture ch2 ch2 racemic mixture racemic mixture one bond I H ch3 CH, CH2 ch3

S〇2 chT"chT ch2 so(cis) 16 10 201138631 Compound number is in the stereochemistry of *L R1 Y1 Y2 11 racemic mixture ch2 ch3 ch2 so(trans) 12 racemic mixture ch2 ch3 ch2 so, 13 racemic mixture ch2 H ch2 s 14 racemic mixture ch2 H ch2 so (cis) 15. racemic mixture ch2 H ch2 s〇(>CST~ 16 racemic mixture ch2 H ch2 S〇2 19 S key CH, s CH, 20 S key CH, so (cis _) cS~ 21 S key ch3 so (trans) ---- CH, 22 S . key ch3 S〇2 CH, 23 S key H s CH, 24 S key H so (cis) CH, 25 S key H so (trans) —CH, 26 S key HS〇2 cn2 27 S ch2 ch3 ch2 s 28 S ch2 ch3 ch2 so(cis) 29 S Ch2 ch3 ch2 so (trans) 30 S ch2 ch3 ch2 so, 31 S ch2 H ch2 s 32 S ch2 H ch2 so (cis) 33 S ch2 H ch2 soc^T 34 S ch2 H ch2 so2 The present invention encompasses all formulas (i) an isomer of a compound, a salt thereof, and an N-oxide, comprising a mirror image isomer, a non-image isomer, and a tautomer. Component A can be any type of an isomer of the formula Mixture, or may be substantially single An isomer. For example, wherein γΐ or γ2 is s〇, knife A can be a mixture of cis and trans isomers in any ratio, =:Γ99:1', for example, a molar ratio of lG:i to (d), For example, a molar ratio of 2:50:50. For example, in a trans-rich compound. 5, for example, when γΙ or γ2, SO, a mixture of trans compounds 17 201138631 as far as 2 is more than one The trans total amount is, for example, greater than 50%, such as % 60, 65, 70, 75, 80, 85 '90, 95, 96, 97, preferably ^ at least "%. Similarly, cis-rich compound of formula 1 Mixing (compare: for example, when 丫丨 or S 〇, the cis compound in the mixture is "more than, for example, greater than, for example, at least 55, 6 〇, 65, 7 〇, compared to the total of cis and trans. 75, 80 '85, 90, 95, 96, : 98 or at least 99%. The compound of formula I may be rich in trans-type sulphur. Similarly, the <1 compound may be enriched in cis sulfoxide. For the compounds 6 7 , 10 , 11 , 14 , 15 , 20 ' 21 , 24 , 25 , 28 ' 29 : 32 and 33 in Table A, γ 丨 or γ 2 〇 〇. Each may be a mixture which is separately enriched in cis or trans isomers. In a specific embodiment of the invention, component B is selected from the group consisting of: azotomin, isopipezami, tetraisophthalonitrile, cyclohexazone, difenoconaozle, diacetylene bacterium Amine, dextromethorphan, chlordane, chromozone, arsenic benzene (including arsenic benzene _s_ fluorenyl), defensive ning, siplo, pingke, pugli, zinc and manganese Pu, Propioni Sulphur, Baikemin, Baikeli, Baikefen, Fluopymid, Ipatizine, Roticide, PG, Benzene, Cyclufenamid, Dekli (Tebuconaozle), Trifoxystrobin, Fulu. Illustrative, pentafluorofen, fluoxastrobin, ketoxin-mercapto, phenothiamine, dafoxim, a compound of formula II, a compound of formula III and a compound of formula IV. Preferably, component B is selected from the group consisting of: azotomin, isopipezami, tetraisophthalonitrile, cyclohexyl, difenoconaozle, dipropionin, right extinction Dale, 灭达乐,色18 201138631 % Daan, arsenic benzene (including arsenic benzene-s-methyl), tidying Ning, Saipuo, Pingke, Puckley, Zinc Manganese , prothioconazole, baikemin, white krypton, baikefen, fluorine ° than guanamine, ° ratio. Cefixamide, rot, a compound of formula III and a compound of formula IV. More preferably, component B is selected from the group consisting of: atorine, isopizami, tetrachloroisophthalonitrile, cyclohexyl, chlorfluazene, diclofenac, dextromethorphan, Destroyed, sedative, arsenic benzene (including arsenic benzene-S-methyl), tidying, rot, bismuth compound and compound of formula IV. More preferably, the component lanthanide is selected from the group consisting of: azotomin, ezine, tetrachloroisophthalonitrile, cyclohexazone, chlorhexidine, dipropionin, dextromethorphan, Formula compound and formula ίν, 丄ν compound. The invention also relates to the combination of: a mixture of a compound from the surface oxime and an atmomin. ‘· A mixture of the compound from Table A and the different D Chen Zami. A mixture of the compound from Table A and tetraisoisonitrile. A mixture of the compound from Table A and a looper. A mixture of the compound from Table A and the Kleine. A mixture of the compound from Table A and dipyridinamide. A mixture of the compound from Table A and dextromethorphan. A mixture of the compound from Table A and Verdral. A mixture of the compound from Table A and chroma. A mixture of the compound from Table A and alalic acid benzene. The compound from Table A and the phenyl s_methyl group of the arsenic acid. 19 201138631 A mixture of a compound from Table A and a compound of formula II. A mixture of a compound from Table A and a compound of formula III. A mixture of a compound from Table A and a compound of formula IV. A mixture of the compound from Table A and the lining. A mixture of the compound from Table A and cypro. Mixture of compound from Table A with diced. A mixture of the compound from Table A and Puckley. A mixture of the compound from Table A and zinc manganese. Compound thiophane from Table A. Sitting on a mixture. A mixture of the compound from Table A and dextromethorphan. A mixture of the compound from Table A and white lye. A mixture of the compound from Table A and 100 g of fen. A mixture of the compound from Table A and flupirizine. A mixture of the compound from Table A and penthiopyramine. A mixture of the compound from Table A and the rot. Mixture of compound from Table A with chloramine. A mixture of the compound from Table A and fenpropidin. A mixture of the compound from Table A and cycloflufenamide. A mixture of the compound from Table A and Dekli. A mixture of the compound from Table A and trifloxystrobin. A mixture of the compound from Table A and vinegar. A mixture of the compound from Table A and kexin-indenyl. A mixture of the compound from Table A and benzilifen. A mixture of the compound from Table A and dafphene. 20 201138631 A mixture of a compound from Table A and Emetrol. A mixture of the compound from Table A and Fluoride. A mixture of the compound from Table A and pentafen.

The invention also relates to a method of controlling useful plants or their propagation (IV) plant pathogens, which comprises applying a combination of ... and B to a useful plant, its location or its propagation material; a control, worm, nematode or mollusk pest A method comprising the step of applying a seed of a composition of components A and B to a pest, a locus of a pest, or a plant susceptible to attack by a mites. The seed comprising a mixture comprising a mixture of mash AA B can be provided and/or used in an amount such that it is capable of coordinated pest control. For example, the invention includes a pesticidal mixture comprising a synergistically effective amount of component A and component B; the agricultural composition comprising a synergistically effective amount of a mixture of components VIII and B; Use of a mixture of parts A and B in combating animal pests: synergistically effective amount of the component "B mixture in the use against phytopathogenic fungi; - a method of combating animal pests, including the making of animal pests, Habitats, feeding grounds, food supplies, plants, seeds, soils, areas, materials or animal pests that grow or grow, or materials that are about to be protected from animal infestation or infection, plants, seeds, soil, surfaces Or a space in contact with a mixture of components A and B of an effective amount; a method for protecting crops from attack or infection by animal treasured organisms and/or phytopathogenic fungi, including effective crop 21 201138631 with synergy Contact with a mixture of components 8 and B; one for protecting the roots and shoots of soil seeds and seedlings from soil and leaf worms or plant pathogens A method of bacterium comprising contacting a seed with a synergistically effective amount of a mixture of components A and B before and/or after germination; and comprising, for example, coating a synergistically effective amount of a mixture of components A and B; A method comprising coating a seed with a mixture of components A and B in an effective amount, a method of controlling a plant pathogen (e.g., fungal) disease on a useful plant or on a propagation material thereof, comprising an effective amount of synergy The combination of components A and B is applied to the useful plant, its location or its propagation material. In such applications the mixture of 'A and B will generally be administered in a fungicidal effective amount. The invention also provides a control insect, worm A method of class, nematode or mollusc comprising applying a synergistically effective amount of a combination of components A and B to a pest, a pest locus, or a plant susceptible to pest infestation. In this application, A & The mixture of B will generally be administered in an amount effective to kill insects, acaricidal, nematicidal or molluscicidal agents. In application, components A and B may be used simultaneously or separately. Active ingredient combinations are effective against harmful microorganisms. Such as microorganisms that cause phytopathogenic diseases, especially against phytopathogenic fungi and bacteria. The combination of active ingredients is particularly effective against phytopathogenic fungi belonging to the following classes: Asc〇 mycetes (eg, apple black spot) Genus, venturia, p〇d〇sphaera, Erysiphe, M〇niHnia, Mycosphaerella, Rhododendron (Uncinu丨a); BaSidi〇myCetes (eg Hemneia, potato 22 201138631 black fatigue, Rhizoctonia, Phakopsora, Puccinia, smut (Ustilago) ), swollen black stalk. Tilletia; Fungiimpperfecti (also known as Deuteromycetes; for example, Botrytis, Helminthosporium, ° Rhynchosporium, Fusarium, Septoria, Cercospora, Alternaria, Pyriculari a) and Pseudocercosporella herpotrichoides; Oomycetes (eg Phytophthora, genus peronospora, Pseudoperonospora, white rust) Albugo, Bremia, pythium, Pseudosclerospora, piasmopara. The mixture of the present invention can be used to control pest pests such as Lepidoptera, Diptera, Hemiptera, Thysanoptera, Ortoptera, Dictyoptera. Infections of Coleoptera, Siphonaptera, Hymenoptera, and Isoptera, and other chiropractic pests, such as mites, nematodes, and mollusc pests. Insects, mites, nematodes, and mollusks are collectively referred to hereinafter as animal pests. Such animal pests that can be controlled by the use of the compounds of the invention include such agricultural and agricultural sources (the term includes food, and fiber production: growth of crops), horticulture and animal farming, pets, forest products, and vegetable sources (eg, Fruits, glutinous grains and wood) are harmful to the storage of the products. 23 201138631 There are: 私 ° '° 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私 私According to the present invention, "useful plants" typically include the following plant members (four) vines; mites (such as wheat, barley, buckwheat or oats) ), sweet = sugar beet or fodder beet); fruit (such as pome fruit, stone fruit or:: such as rhodops, pears, plums, peaches, almonds, cherries, mothers, raspberries or blackberries); legumes (eg beans, lentils, bowls of beans or soybeans); oil-stepping plants (eg rapeseed, mustard 'chicken' 撖 ' ' to hollyhock, coconut 'leaf sesame oil plant, cocoa bean or groundnut); cucumber family (eg Meng Reed, cucumber or melon); fiber plant (such as cotton, flax, hemp or jute citrus fruit (such as orange, lemon, grapefruit or (four)); vegetable table (such as vegetables,; g; poor tea @ - anti-existence, cabbage, carrots, onions, tomatoes, potatoes, gourds or sweet peppers; earthworms (such as avocado, cinnamon or alfalfa 'corn' tobacco; nuts; coffee; sugar cane; tea; Tree; hop; durian; scented; natural rubber plant; lawn or ornamental plant (such as flowers, shrubs, broadleaf trees or evergreen plants, such as pines and cypresses). This list does not represent any restrictions. The term "useful plants" should be understood To include herbicides or several types of herbicides such as HPPD inhibitors; ALS inhibitors such as flufensulfuron which are resistant to bromnebenzil (br〇m〇xynii) by conventional breeding or genetic engineering methods. Primisulfuron, flusulfuron-methyl and trifl0xysulfur〇n; Epsps (5-enolpyruvylsulfonyl-shikimate-3-phosphate synthase) inhibitor; GS (glutamate synthase) inhibitor 24 201138631 « Useful plants. An example of a crop that has become resistant to imidazolinones (such as imamamox) by the conventional breeding (mutation-induced) method is Clearfield® summer rape (Canola). Examples of crops that have been resistant to several herbicides or herbicides by genetic engineering methods include the glyphosate resistant and glufosinate resistant varieties commercially available under the trade names RoundupReady®, Herculex I®, and LibertyLink®. The term "useful plant" is also understood to also include useful plants which have been transformed by the use of recombinant DNA techniques to enable their synthesis of one or more selectively acting toxins, such as, for example, bacteria known to produce toxins, especially These toxins produced by bacteria of the genus Bacillus. Toxins which can be expressed by such transgenic plants include, for example, insecticidal peptones such as Bacillus cereus or the insecticidal proteins of Bacillus popliae; or Bacillus thuringiensis. Insecticidal proteins, such as endotoxin, such as CrylA(b), CrylA(c), CrylF, CryIF(a2), CryllA(b), CrylllA, CrylllB(bl) or Cry9c, or vegetative insecticidal proteins (VIP) ) ' For example, VIP1, VIP2, VIP3 or VIP3A; or insecticidal proteins of bacteria colonizing nematodes, such as Photorhabdus spp. or Xen〇rhabdus SPP· Ph〇t〇rhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals such as saxitoxin, spider toxin, wasp toxin and other insect-specific neurotoxins; toxins produced by fungi, Such as Streptomyces 25 201138631, phytohemagglutinin (such as cowpea lectin, barley lectin or snowdrop lectin); lectin; protease Formulations such as trypsin inhibitor, 2 amino acid 6 enzyme inhibitor, potato tubulin, cystatin, papain inhibitor; ribosomal protein raft (RIP) 'such as Ricin, corn Rip, abnn, anti-filament seed ribosome inactivating protein, saporin or diarrhea venom (bry〇din); steroid metabolism enzyme , 4 such as 3-hydroxysteroid oxidase, ecdysone _UDp_glycosyltransferase, cholesterol oxidase, ecdysone inhibitor, hmg_c〇a reductase, ion channel blocker (such as sodium or calcium channel resistance) Broken agent), juvenile hormone esterase, diuretic hormone receptor, purine synthase, bibenzyl synthase, chitinase and polyglucose. In the context of the present invention, it is understood that not only 5_ endotoxin is present, such as CrylA(b), CryIA(C), CrylF, CryIF(a2), CryIIA(b)'

CrylllA, CrylllB (bl) or Cry9c, or vegetative insecticidal proteins (VIP), such as VIP1, VIP2, VIP3 or VIp3A, are also apparently present with hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by novel combinations of different domains of their proteins (see, e.g., WO 02/15701). An example of a truncated toxin is the truncated CryIA (b), which is Bt 1 1 corn obtained from Syngenta Seeds SAS as described below. In the case of a modified toxin, one or more amino acids in the naturally occurring toxin are replaced. When replacing such amino acids, it is preferred to insert a non-naturally occurring protease recognition sequence into the toxin, such as in the case of CryIIIA055, inserting the cathepsin recognition sequence into 26 201138631 φ

Among the CrylllA toxins (see w〇 03/018810). The toxins or the transgenic plants capable of synthesizing these toxins

Examples are disclosed, for example, in ΕΡ-Α-0 374 753, WO 93/07278, WO

95/34656, ΕΡ-Α-0 427 529, EP-A-451 878 and WO 03/052073. Methods of preparing such specialized transgenic plants are generally known to those skilled in the art and are described, for example, in the above publication. Cryi-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, ΕΡ-Α-0 367 474, ΕΡ-Α-0 401 979 and WO 90/13651. The toxins contained in the transgenic plants make the plants resistant to harmful insects. Such insects may be present in any taxonomic group of insects, but are particularly common in beetles (coleoptera), double-winged insects (Diptera), and butterflies (Lepidoptera). Transgenic plants containing one or more genes encoding insecticidal resistance and exhibiting one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (a corn variety that expresses CryIA(b) toxin); YieldGard Rootworm® (a corn variety that exhibits CrylllB(bl) toxin); YieldGard Plus® (expressive of CrylA(b) and CrylllB (bl) a toxin-changing maize variety; Starlink® (a maize variety that expresses Cry9(c) toxin); Herculex I® (expressing CryIF (a2) toxin and phosphinothricine N-acetyltransferase; PAT ) a corn variety that is tolerant to the herbicide solids; a NuCOTN 33B® (a cotton variety that exhibits CrylA(c) toxin); a Bollgard I® (a cotton variety that exhibits a CrylA(c) toxin 27 201138631 species Bollgard II® (cotton variants showing CrylA(c) and CryIIA(b) toxins; VIPCOT® (cotton variants showing VIP toxins); NewLeaf ® (potato variants showing CrylllA toxins); NatureGard® and Protecta®. Other examples of such genetically modified crops are: l. Btll corn, obtained from Syngenta Seeds SAS, Chemin de l& apos, Hobit 27, F-31790 St. Sauveur, France 'Registration No. C/FR/96/05/ 10. Genetically engineered maize (Zea mays), which has been shown to be resistant to European corn borer (〇strinia nubilaUs and Sesamia nonagrioides) by expressing truncated CryIA(b) toxins in a transgenic manner. ) Invasion. Btl! Corn also expresses the enzyme PAT in a transgenic manner to achieve tolerance to the herbicide acetochlor. 2 'Btl76 Corn' was obtained from syngenta seeds SAS, Cheminde l& apos, Hobit 27, F-3 1 790 St. Sauveur, France, registration number C/FR/96/G5/1G. Genetically engineered maize has been rendered resistant to attack by European corn borer (corn borer and pink stem borer) by expressing CrylA(b) toxin in a transgenic manner. The BU76 maize also expresses the enzyme PAT in the form of a transgenic gene to achieve tolerance to the herbicide acetochlor. 3. MIR604 Jade, obtained from Syngenta Seeds SAS, Chemin de bit 27, F-3i79〇 st. Sauveur, France, registration number C/FR/96/05/10. ρ» 丄,, soil ± + w . ^ 4a has been modified by the transfer gene

CrylllA toxins make corn resistant to insects. This toxin is modified by insertion, and, and my protease protease recognition sequence.

Cry3A055. The preparation of such transgenic maize plants is described in 28 201138631 03/018810. 4. MON 863 Corn, obtained from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-11 50

Brussels, Belgium, registration number C/DE/02/9. MON 863 exhibits CrylllB(bl) toxin and is resistant to certain coleopteran insects. 5. IPC 531 cotton, available from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-l 150 Brussels, Belgium, registration number C/ES/96/02. 6.1507 Maize, obtained from Pioneer Overseas, Avenue Tedesco, 7B-1160 Bruss.eIs, Belgium, registration number C/NL/00/10. Genetically engineered maize, which expresses the protein Cry 1 F, is resistant to certain lepidopteran insects and exhibits PAT protein to achieve herbicide solidification. 7·ΝΚ603χΜΟΝ 810 Corn, obtained from Monsanto Europe S. A.270-272 Avenuede Tervuren, B-1150

Brussels, Belgium, registration number C/GB/02/M3/03. It consists of a genetically engineered variety NK603 and MON 810 hybrid hybrid varieties that are cross-bred in a conventional manner. NK603XMON 810 maize expresses the protein CP4 EPSPS in a transgenic manner (this protein is obtained from the Agrobacterium sp. CP4 strain and confers tolerance to the herbicide Roundup (containing glyphosate)) and CrylA(b) Toxin (this toxin is obtained from Bacillus thuringiensis subsp. kurstaki and confers tolerance to certain lepidoptera (including European corn fill)). 29 201138631 Genetically modified crops of insect-resistant plants are also described in BATS (Zentrum fur Biosicherheit und

Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4〇58

Basel, Switzerland) Report 2003. (http://bats.ch). The term "useful plant" is understood to also include useful plants which have been transformed by the use of recombinant DNA techniques to enable them to synthesize selective anti-pathogenic substances such as the so-called "pathogenic associated proteins" (see also For example ΕΡ-Α-0 392 225). Examples of such anti-pathogenic substances and transgenic plants capable of synthesizing such anti-pathogenic substances are known, for example, from ΕΡ-Α-0 392 225, W0 95/33818 and ΕΡ-Α-0 353 191. Methods of preparing such transgenic plants are generally known to those skilled in the art and are described, for example, in the above publication. Antipathogenic agents which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers of nano and I bow ion channels, such as viral KP1, KP4 or KP6 toxins; K synthase; synthase Chitinase; polyglucose; so-called "pathogenic associated proteins" (PRP, see eg ΕΡ-Α-0 392 225); anti-pathogenic substances produced by microorganisms such as peptide antibiotics or heterocyclic antibiotics (see for example W〇95/33 8 18) 'Or a protein or polypeptide factor involved in plant pathogen defense (the so-called "plant disease resistance gene", as described in WO 03/000906). Useful plants include soybeans, corn, sugar cane, alfalfa, mustard vegetables, canola (such as rapeseed), potatoes (including sweet potatoes), cotton, rice 'coffee' citrus, almonds, fruit vegetables (such as tomatoes, peppers, peppers, stand 'Cucumber' squash, etc.), tea, soaked vegetables (such as onions, 201138631 leeks, etc.), grapes, pear fruit (such as apples, pears, etc.), stone fruits (such as pears, plums, etc.). Useful plants for increasing interest in the present invention are cereals; large and 'rice, canola; pome fruit; stone fruit; peanuts; coffee; tea; grass berries, turf, vines and vegetables such as tomatoes, potatoes, gourds and lettuce. The term "location" of a useful plant is used in this article. • ~ f Λ: *, stone man. The place where the plant grows, the place where the plant propagation material of the plant is sown, or the soil where the plant's propagation material is put will be badly placed. An example of this type of location is a field for plant growth. The term "plant propagation material" is understood to mean the reproductive part of a plant, such as a seed, which can be used for the propagation of the latter, and vegetative growth substances such as cuttings or tubers (e.g., potatoes). Mention may be made, for example, seeds (narrow sense), roots, fruits, flutes, seven Yin brothers, roots, and parts of plants. It is also possible to mention sprouts and seedlings which will be transplanted after germination or after germination from the soil. These seedlings can be protected by whole or partial treatment by dipping prior to transplantation. It should be understood that the preferred "plant propagation material" means seeds. (4) For the treatment of seeds, the agents that are of interest include the protection of Ning, the rot: Xing'an, the right halal, and the genus. According to the above, in a specific example, component B is selected from the group consisting of: binding, taiji, taiwan, ruthenium, dextran, dextromethorphan and halal. A further aspect of the invention is a natural product that protects plants and/or animal sources derived from the natural life cycle, ", shellfish and/or its processed form from true extracts and/or animal pests; The invasive, ., ν method comprises administering a combination of the effective amount of the component Α and hydrazine to a natural product 31 201138631 or a processed form thereof. According to the invention, the term "from the natural life paper&" + p% period of the plant source of the day 6 means that the freshly harvested plant or part thereof harvested by the natural life cycle. Examples are stems, leaves, tubers, seeds, fruits or grains. According to the date of the present invention, the term ": the processed form of the natural substance of the provenance" is understood to be the natural source of the plant that represents the fruit of improved processing. The form of the substance. The improved processing can be used to: convert the natural source f of the plant source into a storage form of more or more of the substance (storage goods such as the modified jade are pre-dried, wet, crushed, crushed 'grinding, compressing or baking. The processing form of the natural material that is also a plant source is defined as wood, whether in the form of logs such as wooden chairs, electric towers and fences, or in the form of finished products, such as furniture made from wood or According to the invention, the term "natural material derived from the source of the natural life cycle and/or its processed form, is understood to mean a substance derived from an animal such as a leather skin. Leather, fur, hair and the like. The combination according to the invention can also be used to prevent adverse effects such as spoilage 'discoloration or mold. - a preferred embodiment is a natural substance that protects plant sources derived from the natural life cycle and/or Their form of processing is not affected by fungi and/or

A method of pest infestation comprising applying a synergistically effective amount of a combination of components A and B to a natural material and/or animal source of the plant or a processed form thereof. Another preferred embodiment is a fruit that protects the natural life cycle 32 201138631 (preferably from pome fruit, nucleus, berry-like and citrus fruits) and/or their processed form, '/, contains The synergistically effective amount of the combination of components A and B is applied to 5 呤 & to 6 HAI plants of natural materials and / or their forms of work. The heart of the month, 'and. It can also be used in the field of protecting industrial materials from fungal attack. The term "industrial material" in accordance with the present invention indicates that a non-living material has been prepared for use in the industry. For example, industrial materials intended to protect against fungal attack can be rubber, rubber, paper, board, textile, carpet, leather, wood, construction, paint, plastic articles, cooling lubricants, water hydraulic fluids, and others. A material that can be invaded or decomposed by microorganisms. From the materials to be protected, 'cooling and heating systems, ventilation and air conditioning systems, and parts of manufacturing plants, such as cooling water circulation, that are damaged by microbial growth can also be mentioned. Combinations according to the invention can also be used to prevent adverse effects such as spoilage, discoloration or mold. Combinations of the invention may also be used in the field of protecting technical materials from fungal attack. According to the invention, the term "technical material" includes paper; carpets; buildings; cooling and heating systems; exhaust and air conditioning systems and the like. Combinations according to the invention can also be used to prevent adverse effects such as decay, discoloration or mold. The combination according to the invention is resistant to powdery mildew; rust; leaf spot; early blight and mold; especially against the genus Aspergillus, rust, white genus, Pyrenophora and pseudo-tail Tapese; phak〇ps〇ra in soybean; Hemileia in coffee; Rhizopus genus 33 201138631 (Phragmidium) in rose; Tomatoes and gourds in the horseshoe crabs (10) (10) aria); in the lawn 'vegetables' to Ricai and rapeseed: Sclerotinia; black rot, red fire ant, powdery mildew in the vine, Botrytis and blight; gray mold in fruits (B〇trytis

Cinerea); it is particularly effective in the fruit of the genus M0nilinia spp. and in the fruit of the genus Penicillium spp. The combination according to the invention is furthermore resistant to seed-borne and soil-borne diseases, such as Alternaria spp, Ascochyta Spp., Botrytis, cerc〇sp〇 Ra spp.), Claviceps purpurea, Cochliobolus sativus, Colletotrichum spp., Epic〇ccum spp, and Fusarium graminearum Fusarium graminearum), Fusarium moniliforme, Fusarium oxysporum, Fusarium pr〇liferatum, Fusarium solani, Fusarium Subglutinans)' Gaumannomyces graminis, Helminthosporium spp., Microdochium nivale, Phoma spp., Barley leaf spot (Pyrenophora graminea)., Pyryuiaria oryzae, Rhizoctonia solani, Rhizoctonia cerealis, Sclerotinia sclerotiorum Sclerotinia spp_), Septoria spp., Sphacelotheca reiliana, Tilletia spp. 'Merce snow rot brown 34 201138631 Helicobacter pylori (TyPhula incarnata) ), Urocystis occulta, Ustilago spp. or Verticillium spp.; especially against cereals such as wheat, barley, rye or oats, corn, rice ; cotton; soybean; lawn; beet; rape; horse potato; bean crops such as cowpea, lentils or chicken beans; and sunflower pathogens are particularly effective. The composition according to the invention counters post harvest diseases such as Botrytis, Colletotrichum musae, curvularia lunata, Fusarium semitecum, Geotrichum candidum ( Geotriclmm candidium), M〇niUnia fructicola, Monilinia fructigena, Monilinia laxa, Mucor piriformis, Penicillium italicum ), Peniciliium solitum, Penicillium (PenicilUum), or penicillium expansum, especially against fruits, such as pome fruit, for example, apples and pears, stone fruits, for example Peach and plum, citrus, melon, papaya, kiwi, mango, raspberry, for example, grass, pear, stone and banana; and nut pathogens are particularly effective. The combination according to the invention is used to control the following plant diseases. Effective: Alternaria species in fruits and vegetables, and crops Species of the genus Asc〇chyta, 35 201138631 Botrytis in strawberries, tomatoes, hollyhocks, legumes and grapes, Cercospora arachidicola in groundnuts, in stork Cochliobolus sativus, Colletotrichum species in legumes, powdery mildew species in alfalfa, Erysiphe cichoracearum and monofilaments in gourd 5 ?Sphaerotheca fuliginea, a species of genus of genus in the sputum and corn, a sapling of the scorpion in grains and turf, a variegal species in corn, rice and potato, a wheel on coffee Hemileia vastatrix, a species of Microdochium in wheat and rye, a species of rust fungus in soybean, a rust genus in the cultivar 'broad-leaved crops and perennial plants Species, species of the genus Pseudo cere osp or ell a in the scorpion, Phragmidium mucronatum > in the fruit The species of the genus Chaetomium, the species of the genus Lactobacillus in barley, the rice blast fungus in rice, the genus Ramularia collo-cygni in barley, 36 201138631 in cotton, soybeans, scorpions, corn, Phytophthora species in potato, rice and turf, Rhynchosporium secalis in barley and rye, Sclerotinia species in lawn, lettuce, vegetables and canola, in the genus , the species of the genus Aspergillus in soybeans and vegetables, the sphagnum (the §phacei〇theca reilliana) in corn, the species of the genus Phytophthora in the scorpion, the grape powdery mildew in the vine (Uncinuia necator) ), Guignardia bidwel Hi and ph〇m〇psis viticola, rye smut in rye, Ustiiag0 species in cereals and maize , the species of the genus Arthropod on the fruit, the species of the genus Sclerotinia in the fruit, the species of the genus Penicillium on citrus and apple. The combination of the invention is further particularly effective against the following pests: MyZUS persicae (Aphid), Aphis gossypii (Aphid), Aphis fabae (Aphid), LygUS spp. ) (blind wall), red genus (Dysdercusspp.) (blind pheasant), brown planthopper (Nilaparvata lugens) (planthopper), Nephotettixc incticeps (leafh〇pper), green Nezara spp. (stinkbugs), Euschistus spp. (L), Leptocorisa spp., Frankliniella 37 201138631 occidentals (蓟) Horse), Thrips spp. (Puma), potato beetle (Leptinotarsa decemlineata) (Colorado potato beetle), cotton nymph (Anthonomus grandis) (bollworm), shell Aonidiella spp. (prey scale) 'trialeurodes spp. (White flies), Bemisia tabaci (whitefly), European corn borer (0strinia nubilalis) (Europe) Corn turn) Sp〇doptera littoralis) (cotton leafworm), Heliothis virescens (tobacco budworm), Helicoverpa armigera (cotton bollworm), Helicoverpa Zea), cotton leafhopper (Sylepta derogata) (cotton leaf beetle), Pieris brassicae (white butterfly), piutella xylostella (diamond back moth), ground tiger Genus (Agrotis spp_) (cutting rootworm), Chilo suppressalis (rice borer), Locusta migratoria (worm king), Australian aphid (Chortiocetes terminifera) (locust), leaves Diabrotica spp. (rootworm), Panonychus ulmi (European red dragonfly), Panonychus citri (hanging orange worm), and Tetranychus urticae (two-spotted spider mite), Tetranychus cinnabarinus (carmine spider mite), Phyllocoptruta oleivora (citrus rust mite) Side multi-food line worm (polyphagota Rsonemus latus), Brevipalpus spp. (flat mites), Boophilus 38 201138631 microplus (burdock), Dermacentor variabilis (American dog licking) ), Ctenocephalides felis (|Nursery), Liriomyza spp. (leafminer), Musca domestica (Housefly), Aedesaegypti (Aedesaegypti) Mosquito, Anopheles Spp. (mosquito), Culex Spp. (mosquito), Lucillia spp_ (blowflies), German Latitude (Blattella germanica) ) (Weft), Periplaneta americana (蟑螂), Blattorialalis (蟑螂), Mastotermitidae (such as Mastotermes spp.), Kalotermitidae (such as new termites) (Neotermes spp.), Rhinotermitidae (such as Coptotermes formosanus, Reticulitermes flavipes, R. speratu, R. virginicus, R. hesperus, and mulberry Special termite (R. santonensis )) and termites (Termitidae) (eg, Globitermes sulphureus) termites, tropical fire ants (Solenopsis geminata) (fire ants), small yellow ants (Monomorium pharaonis) (Pharaoh ants), Ranunculus (Damalinia spp.) and Linognathus spp. (biting lice and sucking lice), Meloidogyne spp. (root nodule), cystoid nematode (Globodera spp_) And Heterodera spp. (cystic nematode), genus Pratylenchus spp. (lesi〇n nematodes), Rhodopholus spp. (tank nematode), Tylenchulus Spp_) (Citrus elegans), Haemonchus Contorlus (barber pole 39 201138631 worm), Caenorhabditis elegans _ (vinegaf eelworm), hair circle Nematode (trich〇str〇ngylus spp.) (digestive nematode) and garden ash (Der〇ceras reticulatum) (insect life). The amount of the composition of the invention to be administered will depend on various factors, such as the compound employed; the subject of the treatment (such as, for example, a plant, soil or seed treatment (eg, for example, spraying, dusting or seed dressing); For example, prophylaxis or treatment; depending on the type of fungus to be controlled or the time of administration. A mixture comprising the compound of formula I selected from Table A and one or more of the above active ingredients may, for example, be in the form of a single "premixed mixture". a combination of separate formulations of a single active ingredient component, such as a "tank mixture", and when applied in a sequential manner, ie within a reasonable: short period of time, such as hours or days - one after the other Administration: Application in combination with a single active ingredient. The order in which the compound of the formula selected from the formula and the above-mentioned active ingredient are administered is not an embodiment of the present invention. The fungicidal and/or composition of the composition of A + B is taken. Or when the animal pesticidal activity is greater than the sum of the fungicidal activity and/or the detoxification activity of a and B, there is a synergistic total of the synergistic component 、, its location or its reproduction. The method comprises applying the component A and the amount as a blend or separately to the useful plant material β blade. Some of the plates according to the invention have a phylogenetic, soil-defective and seed treatment pesticide. The system acts as a 201138631 Using the composition according to the invention, it is possible to inhibit or destroy phytopathogenic microorganisms and/or harmful animals in parts of plants or plants (fruits, flowers, leaves, shoots, tubers, roots) which are present in different useful plants, At the same time, it also prevents some plants that grow later from being attacked by pathogenic microorganisms and/or harmful animals. A~" UW 有用 隹 有用 useful species or seeds thereof, especially in agricultural crops, such as horse bells, Tobacco and sugar beets and wheat, buckwheat, barley, oats, rice, corn, lawn, cotton, soybeans, rapeseed, peas farming in horticulture and viticulture: hornet, coffee, sugar cane, fruit and ornamental Plants; fungi in vegetables such as cucumbers, soybeans, and gourds. ▲ Once the fungus is treated with the combination according to the present invention, the synergistic combination: the combination of the components of the quantity eight and the B Useful plants that are threatened by fungi, 2 in situ, their reproductive material, plants derived from the natural life cycle and/or animal derived natural materials and/or their processing forms, or industrial materials. Combinations according to the invention may be useful plants , its reproductive material, natural substances from plants and/or animal sources derived from the natural life cycle and/or processing: ^' or industrial materials applied by fungal infection or before / gram, tongue,)! = / 1 useful When plant, the application rate of the compound of formula 1 is 500 ί, and 1 to 5 g of active ingredient per hectare, especially: 1 to 2 g of active ingredient per hectare component. The propagation material (for example, seed treatment) may be 1 to 10 g/kg of 〇·〇〇. When made 41 201138631

When using the combination of the invention for treating seeds 'generally 1 to 5 compounds per kg of seed, preferably from _ to gram I and 〇._ to 5 gram of component B compound per kg of seed jin = The application of 0.01 to 1 Gg/kg of seed per stomach is sufficient. The weight ratio of A to B is generally between the reward: ... period. In another specific example, the weight ratio of A xiao b can be between 500:1 and 1:500, and you 丨 "into, Λ, for example between 100:1 and 1:1", such as I is between 1:50 and 50.1, for example between 1:2 〇 and 2 〇 1. The present invention also provides a pesticidal mixture comprising a synergistically effective amount of components VIII and 如 as described above. Combinations and agriculturally acceptable carriers and, if desired, surfactants. The compositions of the present invention can be used in any conventional form, such as 'dose with dual packaging, dry seed treatment (DS), seed treatment Emulsion (ES) 'Fluidity concentrate for seed treatment (Fs), solution for seed treatment (LS), water-dispersible powder for seed treatment (ws), capsule suspension for seed treatment (CF) , gel for seed treatment (GF), emulsion concentrate (EC), suspension concentrate (s〇' suspension emulsion (se), capsule suspension (CS), water-dispersible granule (WG), emulsifiability Granules (EG), water-in-oil emulsions (E〇), oil-in-water emulsions (Ew), microemulsions (ME), dispersible oil suspensions (OD), Oil suspension (OF), oil soluble liquid (0L), soluble concentrate (SL), ultra low volume suspension (su), ultra low volume liquid (UL), technical concentrate (TK) , a dispersible denture (DC), a wettable powder (wp), or any technically feasible formulation in combination with an agriculturally acceptable adjuvant. 42 201138631 These compositions can be prepared in a conventional manner , for example, by mixing: ingredients and appropriate inerting agents (diluents, solvents, fillers and other optional ingredients such as surfactants, biocides, antifreeze: adhesives, thickeners) And compounds that provide adjuvant effects. It is also possible to use conventional sustained-release formulations that are intended to achieve long-lasting efficacy. In particular, in spray form, such as water-dispersible concentrates (eg EC, SC, DC, ; EW ' Ε (〇 and analogs), wettable powders and granules. (4) The formulation may include surfactants such as wetting agents and dispersing agents, and other compounds for auxiliary effects, such as Alu and naphthyl acid salts, and aryl aryl groups. Acid salt, lignosulfonate, fatty alkyl sulfur Salts and condensation products of ethoxylated alkylphenols and ethoxylated fatty alcohols. Dressing formulations of the compositions and diluents of the invention are in the form known in the art in a suitable dressing formulation, for example An aqueous suspension or dry powder form having good adhesion to the art, and application to the bubble is known in the art. These dressing formulations may be included in the form of a sealant- The active ingredient or a combination of active ingredients, for example, a sustained release capsule or microcapsule. Typical tank mix formulations for seed treatment applications include 〇25 to 8 〇 desired ingredients and 99,75 to Zhejiang, palpitations疋 to (1) 〇 main 20 / 〇, especially 99 to 25% of solid or liquid auxiliaries (including, for example, &; paralysis i u1 column such as heart agent such as water), wherein the auxiliaries can be formulated with a mixture of tanks The substance is measured as G to surgery. In particular, 鄕 interfacial activators. Typical premix mixtures for seed treatment applications include from 55 to 99.9%, especially 1^95% of the desired ingredients, and 99 5 to 1·1 %, especially 疋99 to 5% of solid or liquid auxiliaries (including For example, solvent 43 201138631 such as water) 'wherein the adjuvant may be from about 50%, especially from 0.5 to 40%, of surfactant in the premix formulation. In general, the formulation comprises from 〇.〇丨 to 90% by weight of active ingredient, from 0 to 20% by weight of an agriculturally acceptable surfactant and from 1% to 99.99% by weight of a solid or liquid formulation inert and adjuvant. (Active) The active agent consists of at least a compound of the formula I and a compound of the component quinone, and optionally a pharmaceutically active agent, in particular a microbicide or preservative or the like. The concentrated form of the composition typically comprises between about 2 and 8% by weight, preferably between about 5 and 7% by weight of active agent. The form of application of the formulation may, for example, comprise from 1 to 2% by weight of hydrazine, preferably from 0.01 to 5% by weight of active agent. Preferably, however, commercial products are formulated into concentrates, and the user typically uses a diluted formulation. There is a synergistic effect when the effect of the s/tongue component combination is greater than the total effect of the individual components. The intended effect of the active ingredient composition for cockroaches is to comply with the so-called COLBY formula and can be calculated as follows (c〇LBY, SR "calculating the synergistic and antagonistic response of the herbicidal composition", Weeds, Vol. 15, No. 2 Page 22, 1967): ppm = active ingredient (= ai) in milliliters per liter of spray mixture X - active ingredient A) using p ppm active ingredient 0 / 〇 Y - using q ppm active ingredient Effect of active ingredient β) % According to COLBY 'The active ingredient A) using p + q ppm active ingredient A) + B) The expected (addition) effect is E = X + Y-^ 100 44 201138631 If the effect of continuous observation ( When the effect of the object is #Λ a (0) is greater than the expected utility (E), the combined effect factor Γ is synergistic. In mathematical terms, the increase is (4) in 0/Εβ in agricultural operations, then ·2 A significant improvement over the conventional two-pure complementary addition (expected activity), and in practice, (iv).9 represents the loss of activity compared to the expected activity. Tables 1 to 198 show the mixtures and compositions of the present invention. It confirms the control of a wide range of fungi. Right _ λ / up, two cases of the compound of formula I (Iv) the significant role to enhance the killing of Shu _ fungicidal compound of the formula itself: generally have any fungicidal effect 'surprising effect of this system.

It is worth noting that Xiao Kui A 1 3» Jt h U 1 and Atomin, Iso-Pezime, Tetrachloroisophene, Glucosamine, Klein, Bifidomycin, dextromethorphan, (1) a compound or a mixture of compounds of formula iv; including A5 and atropine, isoprene, tetraisophthalonitrile, cycloheximide, chlorhexidine, dipropionin, dextromethorphan's compound or formula a mixture of IV compounds; including A6 and a mixture of atropine, isoprene, tetraisophthalonitrile, cycloheximide, dipropionamide, dextromethorphan, hydrazine, or a compound of formula IV Including A6 and A7 and a mixture of Atomin, Isoprozamide, Tetrachloroisocyanonitrile, Cyclosporine, Klein, Dipropionamide, dextromethorphan, a hydrazine compound or a compound of formula IV, including A8 and a mixture of atropine, isopipezide, tetraisophthalonitrile, cyclohexyl, ketone, di-propargylamine, dextromethorphan, a compound of formula III or a compound of formula IV. Pythium ultimum (seedling disease) · The mycelial fragment of the fresh liquid medium of the fungus is directly mixed into the nutrient medium 45 201138631 (potato glucose broth). After the (DMSO) solution of the test compound was placed in a microtiter plate (96-well format), a nutrient medium containing fungal spores was added. The test discs were incubated at 24 ° C and the inhibition of growth was measured spectrophotometrically 48 hours after application. The application rate is as shown in the table. Table 1 A1 PPMAI Atomin A1 Average death % The expected control of Atomic is actually controlled 20 0.5 0 20 20 20 20 1 0 20 20 20 10 0.5 0 20 20 20 5 0.25 0 0 .0 20* 20 2 0 50 50 50 10 1 0 20 20 20 5 0.5 0 20 20 20 10 2 0 50 50 50 5 1 0 20 20 20 2.5 0.5 0 20 20 20 1.25 0.25 0 0 0 20* 5 2 0 50 50 50 2.5 1 0 20 20 20 1.25 0.5 0 20 20 20 0.625 0.25 0 0 0 20* 0.3125 0.125 0 0 0 20* Table 2 PPMAI mean death % Expected control Actual control A1 Tetrachloroisocyanonitrile A1 Four different gases Benzonitrile 20 2 0 20 20 0 10 2 0 20 20 0 5 2 0 20 20 0 Table 3 PPMAI mean death % | Expected control | Actual control 46 201138631 A1 Right to Dallas A1 Right to Dart 20 0.5 0 90 90 100* 10 0.25 0 70 70 70 5 0.125 0 50 50 70* 2.5 0.0625 0 20 20 20 1.25 0.03125 0 20 20 20 0.625 0.015625 0 20 20 20 10 0.5 0 90 90 90 5 0.25 0 70 70 90* 2.5 0.125 0 50 50 50 1.25 0.0625 0 20 20 20 0.625 0.03125 0 20 20 20 0.3125 0.015625 0 20 20 20 5 0.5 0 90 90 90 2.5 0.25 0 70 70 70 1.25 0.125 0 50 50 5 0 0.625 0.0625 0 20 20 20 0.3125 0.03125 0 20 20 20 0.15625 0.015625 0 20 20 . 20 2.5 0.5 0 90 90 90 1.25 0.25 0 70 70 70 0.625 0.125 0 50 50 50 0.3125 0.0625 0 20 20 20 0.15625 0.03125 0 20 20 20 0.078125 0.015625 0 20 20 0 1,25 0.5 0 90 90 90 0.625 0.25 0 70 70 70 0.3125 0.125 0 50 50 50 0.15625 0.0625 0 20 20 20 0.078125 0.03125 0 20 20 20 0.0390625 0.015625 0 20 20 20 Table 4 PPMAI mean death % Expected Control 'Actual Control A5 Atomic A5 Atomione 20 0.5 0 50 50 50 10 0.25 0 20 20 20 20 1 0 70 70 70 47 201138631 10 0.5 0 50 50 20 5 0.25 0 20 20 0 10 1 0 70 70 70 5 0.5 0 50 50 20 2.5 0.25 0 20 20 0 5 1 0 70 70 90* 2.5 0.5 0 50 50 50 1.25 0.25 0 20 20 20 5 2 0 100 100 100 2.5 1 0 70 70 70 1.25 0.5 0 50 50 50 0.625 0.25 0 20 20 20 Table 5 A5 PPMAI Tetraisophthalonitrile A5 Average death % Four gas isophthalonitrile expected control Actual control 20 2 0 50 50 50 10 2 0 50 50 50 5 1 0 0 0 20* 5 2 0 50 50 70* Table 6 A5 PPMAI Right Destroy A5 Average Death % Right De Dal Actual control of the period 10 0.25 0 90 90 90 5 0.125 0 70 70 70 2.5 0.0625 0 50 50 50 1.25 0.03125 0 50 50 50 0.625 0.015625 0 20 20 20 5 0.25 0 90 90 90 2.5 0.125 0 70 70 70 1.25 0.0625 0 50 50 50 0.625 0.03125 0 50 50 50 0.3125 0.015625 0 20 20 20 2.5 0.25 0 90 90 90 1.25 0.125 0 70 70 70 0.625 0.0625 0 50 50 50 0.3125 0.03125 0 50 50 50 48 201138631 0.15625 0.015625 0 20 20 20 1.25 0.25 0 90 90 90 0.625 0.125 0 70 70 70 0.3125 0.0625 0 50 50 50 0.15625 0.03125 0 50 50 20 0.078125 0.015625 0 20 20 · 20 0.625 0.25 0 90 90 90 0.3125 0.125 0 70 70 70 0.15625 0.0625 0 50 50 50 0.078125 0.03125 0 50 50 20 0.0390625 0.015625 0 20 20 20 Table 7 A6 PPMAI Atomin A6 Mean Death % Attorney Expected Control Actual Control 20 0.5 .0 20 20 .0 10 0.25 0 20 20 0 20 1 0 20 20 20 10 0.5 0 20 20 0 5 0.25 0 20 20 0 20 2 0 20 20 20 10 1 0 20 20 20 5 0.5 0 20 20 0 2.5 0.25 0 20 20 0 10 2 0 20 20 20 5 1 0 20 20 20 2.5 0.5 0 20 20 0 1.25 0.25 0 20 20 0 Table 8 A6 PPMAI Chloroisophthalonitrile mean death % A6 Four gas isophthalonitrile expected control actual control 20 2 0 50 50 90* 10 1 0 0 0 50* 10 2 0 50 50 50 5 1 0 0 0 50* 5 2 0 50 50 70* 2.5 1 0 0 0 70* 49 201138631 Table 9 A6 PPMAI Right Vodafone A6 Average Death % Right Fendare Expected Control Actual Control 10 0.25 0 70 70 70 5 0.125 0 70 70 70 2.5 0.0625 0 50 50 50 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.625 0.0625 0 50 50 50 0.3125 0.03125 0 20 20 0 2.5 0.5 0 100 100 90 1.25 0.25 0 70 70 70 0.625 0.125 0 70 70 50 0.3125 0.0625 0 50 50 50 0.15625 0.03125 0 20 20 20 0.625 0.25 0 70 70 90* 0.3125 0.125 0 70 70 70 0.15625 0.0625 0 50 50 50 0.078125 0.03125 0 20 20 20 Table 10 A8 PPMAI Atomin A8 Average Death % Atomin Expected Control Actual Control 20 0.5 0 20 20 20 20 1 0 20 20 20 10 0.5 0 20 20 20 20 2 0 20 20 20 10 1 0 20 20 20 5 0.5 0 20 20 0 10 2 0 20 2 0 20 5 1 0 20 20 20 50 201138631 2.5 0.5 0 20 20. 0 5 ' 2 0 20 20 20 2.5 1 0 20 20 20 1.25 0.5 0 20 20 0 Table 11 PPMAI A8 Four-isophthalonitrile average death % A8 four The expected control of the gas isobenzonitrile is 20 0 0 0 90* 5 0.25 0 0 0 ne 20 2 0 70 70 70 10 2 0 70 70 50 5 1 0 0 0 20* 2.5 0.5 0 0 0 20* 5 2 0 70 70 50 2.5 1 0 0 0 20* Table 12 A8 PPMAI Right Destroy A8 Average Death % Right Deutera Expected Control Actual Control 20 0.5 0 90 90 90 10 0.25 0 70 70 70 5 0.125 0 70 70 50 2.5 0.0625 0 50 50 20 1.25 0.03125 0 20 20 20 10 0.5 0 90 90 100* 5 0.25 0 70 70 90* 2.5 0.125 0 70 70 50 1.25 0.0625 0 50 50 50 0.625 0.03125 0 20 20 20 0.3125 0.015625 0 0 0 20* 5 0.5 0 90 90 90 2.5 0.25 0 70 70 70 1.25 0.125 0 70 70 50 0.625 0.0625 0 50 50 50 0.3125 0.03125 0 20 20 20 2.5 0.5 0 90 90 90 1.25 0.25 0 70 70 90* 51 201138631 〇·625 0.125 0.3125 0.0625 0.15625 0.03125 1·25 0.5 0.625 0.25 0.3125 0.125 0.15625 0.0625 0078125 0.03125 0 70 0 50 0 20 0 100 0 100 0 90 0 70 0 70 0 50 0 20 70 70 50 , 50 20 20 100 100 100 100 90 90 70 70 70 50 50 50 20 20 Rhizoctonia solani (root rot, seedling disease): fungi from low temperature storage The hyphae fragment was directly mixed in a nutrient medium (potato glucose broth). After the (DMSO) solution of the test compound was placed in a microtiter plate (96-well format), the nutrient medium containing the fungus was placed. The test plate was cultured under the test and the inhibition of growth was measured with a luminometer 48 hours after the application. Application rate as shown in the table:

Table 13 PPMAI mean death % Expected control actual control A1_Yatomin 20 0. 5 10 0. 25 5 0. 125 2. 5 0. 0625 20 1 10 0. 5 5 0. 25 2. 5 0. 125 1. 25 0. 0625 20 2 A1__Atomin 0 20 0 20 0 20 0 20 0 20 0 20 0 20 0 20 0 20 0 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 20 52 201138631 10 1 0 20 20 20 5 0. 5 0 20 20 20 2. 5 . 0. 25 0 20 20 20 1. 25 0. 125 0 20 20 20 0. 625 0. 0625 0 20 20 20 10 2 0 20 20 20 5 1 0 20 20 20 2. 5 0. 5 0 20 20 20 1. 25 0. 25 0 20 20 20 0. 625 0. 125 0 20 20 20 0. 3125 0. 0625 0 20 20 0 5 2 0 20 20 20 2. 5 1 0 20 20 20 1. 25 0. 5 0 20 20 20 0. 625 0. 25 0 20 20 20 0. 3125 0. 125 0 20 20 20 Table 14 PPM AI A1 Isopipezami Mean Death % A1 Isopipezam Expected Control Actual Control 10 0. 25 0 90 90 100* 5 0. 125 0 70 70 90* 2. 5 0. 0625 0 50 50 50 5 0. 25 0 90 90 100* 2. 5 0. 125 0 70 70 90* 1. 25 0. 0625 0 50 50 50 2. 5 0. 25 0 90 90 90 1. 25 0. 125 0 70 70 90* 0. 625 0. 0625 0 50 50 70* 0. 3125 0. 03125 0 0 0 20* 0. 15625 0. 015625 0 0 0 20* 1. 25 0. 25 0 90 90 100* 0. 625 0. 125 0 70 70 90* 0. 3125 0. 0625 0 50 50 90* 0. 15625 0. 03125 0 0 0 90* 0. 078125 0. 015625 0 0 0 70* 0. 0390625 0. 0078125 0 0 0 50* 0. 625 0. 25 0 90 90 100* 0. 3125 0. 125 0 70 70 100* 0. 15625 0. 0625 0 50 50 90* 0. 078125 0. 03125 0 0 0 90* 53 201138631 [0. 0390625 0. 015625 [ 0_0 | 0 | 70* Table 15 PPMAI Mean Death % Expected Control Actual Control A1 Tetraisophthalonitrile A1 Tetraisophthalonitrile 10 2 0 0 0 90* Table 16 A1 PPMAI Ring Block A1 Average Death % Ring The actual control of the expected control of the seat is 20 0. 5 0 0 0 20* 20 1 0 20 20 50* 20 2 0 70 70 70 10 1 0 20 20 20 10 2 0 70 70 70 5 1 0 20 20 20 5 2 0 70 70 70 2. 5 1 0 20 20 20 1. 25 0. 5 0 0 0 20* Table 17 PPMAI A1 Compound ΙΠ A1 Average Death % Compound ΙΠ Expected Control Actual Control 1. 25 0. 03125 0 ‘ 90 90 90 0. 625 0. 015625 0 20 20 50* 0. 625 0. 03125 0 90 90 90 0. 3125 0. 015625 0 20 20 20 0. 3125 0. 03125 0 90 90 100* 0. 15625 0. 015625 0 20 20 90* 0. 078125 0. 0078125 0 0 0 50* 0. 15625 0. 03125 0 90 90 100* 0. 078125 0. 015625 0 20 20 100* 0. 0390625 0. 0078125 0 0 0 100* 0. 078125 0. 03125 0 90 90 100* 0. 0390625 0. 015625 0 20 20 100* Table 18____ PPMAI Average Death % | Expected Control | Actual Control 54 201138631 A5 Isopizami A5 Isopizami 10 0. 25 0 90 90 100* 5 0. 125 0 70 70 70 2. 5 0. 0625 0 20 20 20 .   5 0. 25 0 90 90 100* 2. 5 0. 125 0 70 70 70 1. 25 0. 0625 0 20 20 50* 2. 5 0. 25 0 90 90 100* 1. 25 0. 125 0 70 70 70 0. 625 0. 0625 0 20 20 20 1. 25 0. 25 0 90 90 100* 0. 625 0. 125 0 70 70 90* 0. 3125 0. 0625 0 20 20 50* 0. 625 0. 25 0 90 90 100* 0. 3125 0. 125 0 70 70 90* 0. 15625 0. 0625 0 20 20 20 Table 19 PPMAI mean death % expected control Actual control A5 tetrachloroisophthalonitrile A5 tetrachloroisophthalonitrile 2. 5 1 0 0 0 20* Table 20 PPMAI Average Death % Expected Control Actual Control A5 Ring Block A5 , Ring Block 20 1 0 90 90 90 10 0. 5 0 20 20 20 10 1 0 90 90 90 5 0. 5 0 20 20 50* 5 1 0 90 90 90 2. 5 0. 5 0 20 20 50* 2. 5 1 0 90 90 90 1. 25 0. 5 0 20 20 50* Table 21 PPMAI Average Death % Expected Control Actual Control 55 201138631 A5 Waiting for Kerry A5 Waiting for Kerry 20 1 0 50 50 90* 10 1 0 50 50 90* 5 1 0 50 50 90* 2. 5 1 0 50 50 90* Table 22 PPMAI A5 Compound ΙΠ A5 Average Death % Compound ΙΠ Expected Control Actual Control 1. 25 0. 03125 0 90 90 90 0. 625 0. 015625 0 70 70 0 0. 625 0. 03125 0 90 90 90 0. 3125 0. 015625 0 70 70 70 0. 3125 0. 03125 0 90 90 100* 0. 15625 0. 015625 0 70 70 50 0. 15625 0. 03125 0 90 90 90 0. 078125 0. 015625 0 70 70 70 0. 078125 0. 03125 0 90 90 100* 0. 0390625 0. 015625 0 70 70 70 Table 23 A6 PPMAI Atomin A6 Average Death % Atomin Expected Control Actual Control 20 0. 5 0 20 20 20 10 0. 25 0 20 20 20 5 0. 125 0 20 20 20 20 1 0 20 20 20 10 0. 5 0 20 20 20 5 0. 25 0 20 20 20 2. 5 0. 125 0 20 20 20 20 2 0 20 20 20 10 1 0 20 20 20 5 0. 5 0 20 20 20 2. 5 0. 25 0 20 20 20 1. 25 0. 125 0 20 20 20 10 2 0 20 20 20 5 1 0 20 20 20 56 201138631 2. 5 0. 5 0 20 20 20 1. 25 0. 25 0 20 20 20 0. 625 0. 125 0 20 20 20 5 2 0 20 20 20 2. 5 1 0 20 20 20 1. 25 0. 5 0 20 20 20 0. 625 0. 25 0 20 '20 20 0. 3125 0. 125 0 20 20 20 Table 24 PPMAI A6 Iso-Pezime A6 Average Death % Iso-Pezami Expected Control Actual Control 5 0. 125 0 90 90 90 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 50 50 50 2. 5 0. 125 0 90 90 90 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 50 50 50 1. 25 0. 125 0 90 90 - 90 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 50 50 50 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 70 70 70 0. 15625 0. 03125 0 50 50 50 0. 3125 0. 125 0 90 90 90 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 50 50 0 Table 25 A6 PPMAI Tetraisophthalonitrile A6 Average Death % Tetrachloroisocyanide Expected Control Actual Control 20 0. 5 0 70 70 100* 20 1 0 90 90 100* 10 0. 5 0 70 70 100* 10 1 0 90 90 100* 5 0. 5 0 70 70 100* 5 1 0 90 90 100* 57 201138631 2. 5 0. 5 0 70 70 90* 2. 5 1 0 90 90 100* 1. 25 0. 5 0 70 70 90* Table 26 PPMAI mean death % Expected control Actual control A6 Ring block A6 Ring block 20 0. 5 0 50 50 50 10 0. 25 0 20 20 20 20 1 0 90 90 100* 10 0. 5 0 50 50 50 5 0. 25 0 20 20 0 10 1 0 90 90 100* 5 0. 5 0 50 50 50 2. 5 0. 25 0 20 20 20 5 1 0 90 90 100* 2. 5 0. 5 0 50 50 50 1. 25 0. 25 0 20 20 20 2. 5 1 0 90 90 90 1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 20 20 20 Table 27 A6 PPMAI Waiting for Klein A6 Average Death % Waiting for Klee Expected Control Actual Control 20 0. 5 0 50 50 70* 10 0. 25 0 20 20 20 10 0. 5 0 50 50 50 5 0. 25 0 20 20 20 5 0. 5 0 50 50 70* 2. 5 0. 25 0 20 20 20 2. 5 0. 5 0 50 50 70* 1. 25 0. 25 0 20 20 20 1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 20 20 20 Table 28 58 201138631 PPMAI A6 Compound ΠΙ A6 Average death % Compound m Expected control Actual control 0. 625 0. 015625 0 90 90 90 0. 3125 0. 0078125 0 20 20 20 0. 3125 0. 015625 0 90 90 90 0. 15625 0. 0078125 0 20 20 20 0. 15625 0. 015625 0 90 90 90 0. 078125 0. 0078125 0 20 20 20 0. 078125 0. 015625 0 90 90 90 0. 0390625 0. 0078125 0 20 20 50* 0. 0390625 0. 015625 0 90 90 90 Table 29 A8 PPMAI Atomin A8 Average Death % Atomin Expected Control Actual Control 20 0. 5 0 20 20 20 10 0. 25 0 20 20 20 5 0. 125 0 20 20 20 20 1 0 20 20 20 10 0. 5 0 20 20 20 5 0. 25 0 20 20 20 2. 5 0. 125 0 20 20 20 20 2 0 20 20 20 10 1 0 20 20 20 5 0. 5 0 20 20 20 2. 5 0. 25 0 20 20 20 1. 25 0. 125 0 20 20 20 10 2 0 20 20 20 5 1 0 20 20 20 2. 5 0. 5 0 20 20 ' 20 1. 25 0. 25 0 20 20 20 0. 625 0. 125 0 20 20 20 5 2 0 20 20 20 2. 5 1 0 20 20 20 1. 25 0. 5 0 20 20 20 0. 625 0. 25 0 20 20 20 0. 3125 0. 125 0 20 20 0 Table 30 59 201138631 PPMAI A8 Iso-Pezime A8 Average Death % Iso-Pazami Expected Control Actual Control 5 0. 125 0 100 100 90 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 20 20 20 2. 5 0. 125 0 100 100 90 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 20 20 20 1. 25 0. 125 0 100 100 90 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 20 20 50* 0. 625 0. 125 0 100 100 90 0. 3125 0. 0625 0 70 70 70 0. 15625 0. 03125 0 20 20 50* 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 0 0 0 Table 31 A8 PPMAI ring block A8 Average death % Ring block Expected control Actual control 20 0. 5 0 50 50 50 10 0. 25 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 50 50 50 5 0. 25 0 20 20 0 10 1 0 90 90 100* 5 0. 5 0 50 50 50 2. 5 0. 25 0 20 20 20 5 1 0 90 90 100* 2. 5 0. 5 0 50 50 50 1. 25 0. 25 0 20 20 20 5 2 0 100 100 100 2. 5 1 0 90 90 100* 1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 20 20 20 Table 32 60 201138631 A8 PPMAI Waiting for Klein A8 Average Death % Waiting for Klee Expected Control Actual Control 20 0. 5 0 70 70 50 10 0. 25 0 20 20 20 20 1 0 100 100 90 10 0. 5 0 70 70 70 5 0. 25 0 20 20 20 20 2 0 100 100 100 10 1 0 .  100 100 100 5 0. 5 0 70 70 50 2. 5 0. 25 0 20 20 20 10 2 0 100 100 100 5 1 0 100 100 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 20 20 20 5 2 0 100 100 100 2. 5 1 0 100 100 100 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 20 20 20 Table 3 3 PPMAI A8 Compound III A8 Average death % Compound ΙΠ Expected control Actual control 0. 625 0. 015625 0 70 70 90* 0. 3125 0. 0078125 0 50 50 70* 0. 3125 0. 015625 0 70 70 70 0. 15625 0. 0078125 0 50 50 50 0. 15625 0. 015625 0 70 70 90* 0. 078125 0. 0078125 0 50 50 0 0. 078125 0. 015625 0 70 70 90* 0. 0390625 0. 0078125 0 50 50 70* 0. 0390625 0. 015625 0 70 70 90* All-in-one fungus (Gaewmawwom less ces grami'wbj · Mix the mycelial fragments from the low-temperature storage fungus directly into the nutrient medium (potato 61 201138631 glucose broth). After the DMSO) solution was placed in a microtiter plate (96-well format), a nutrient medium containing fungal spores was added. The test plates were incubated at 24 ° C and the inhibition of growth was measured photometrically at 620 nm 48 hours after application. The application rate is not shown in the table. Table 34 PPMAI A1 Atomin A1 Average death % The actual control of the expected control of Atomin 20 0. 5 0 50 50 90* 10 0. 25 0 20 20 70* 5 0. 125 0 20 20 50* 2. 5 0. 0625 0 0 0 20* 1. 25 0. 03125 0 0 0 20* 0. 625 0. 015625 0 0 0 20* 0. 3125 0. 0078125 0 0 0 20* 0. 15625 0. 00390625 0 0 0 20* 20 1 0 50 50 50 10 0. 5 0 50 50 20 5 0. 25 0 20 20 20 2. 5 0. 125 0 20 20 20 1. 25 0. 0625 0 0 0 20* 0. 625 0. 03125 0 0 0 20* 0. 3125 0. 015625 0 0 0 20* 0. 15625 0. 0078125 0 0 0 20* 0. 078125 0. 00390625 0 0 0 20* 20 2 0 50 50 50 10 1 0 50 50 20 5 0. 5 0 50 50 0 2. 5 0. 25 0 20 20 0 1. 25 0. 125 0 20 20 0 10 2 0 50 50 20 5 1 0 . 50 50 20 2. 5 0. 5 0 50 50 20 62 201138631 1. 25 0. 25 0 20 20 20 0. 625 0. 125 0 20 20 20 0. 3125 0. 0625 0 0 0 20* 0. 15625 0. 03125 0 0 0 20* 0. 078125 0. 015625 0 0 0 20* 0. 0390625 0. 0078125 0 0 0 20* 5 2 0 50 50 50 2. 5 1 0 50 50 50 1. 25 0. 5 0 50 50 20 0. 625 0. 25 0 20 20 20 0. 3125 0. 125 0 20 20 20 0. 15625 0. 0625 0 0 0 20* 0. 078125 0. 03125 0 0 0 20* 0. 0390625 0. 015625 0 0 0 20* Table 35 PPMAI Mean Death % Expected Control Actual Control A1 Iso-Pymidine A1 Isopipeza 20 0. 5 0 0 0 50* 10 0. 25 0 0 0 20* Table 36 PPMAI A1 Tetraisophthalonitrile Average death % A1 Tetraisophthalonitrile Expected control Actual control 20 0. 5 0 20 20 50* 10 0. 25 0 0 0 20* 20 1 0 50 50 50 10 0. 5 0 20 20 20 20 2 0 90 90 70 10 1 0 50 50 50 5 0. 5 0 20 20 20 10 2 0 90 90 100* 5 1 0 50 50 50 2. 5 0. 5 0 20 20 20 5 2 0 90 90 100* 2. 5 1 0 50 50 50 1. 25 0. 5 0 20 20 20 Table 37____ PPMAI Average Death % | Expected Control | Actual Control 63 201138631 A1 Ring Block A1 Ring Block 20 0. 5 0 50 50 50 10 0. 25 0 20 20 20 20 1 0 70 70 90* 10 0. 5 0 50 50 50 5 0. 25 0 20 20 20 20 2 0 90 90 90 10 1 0 70 70 90* 5 0. 5 0 50 50 50 2. 5 0. 25 0 20 20 20 10 2 0 90 90 90 5 1 0 70 70 90* 2. 5 0. 5 0 50 50 50 5 2 0 90 90 90 2. 5 1 0 70 70 70 1. 25 0. 5 0 50 50 20 Table 38 PPMAI Average Death % Expected Control Actual Control A1 Waiting for Klein A1 Waiting for Kelly 20 0. 5 0 0 0 50* 10 0. 25 0 0 0 20* Table 39 PPMAI mean death % Expected control Actual control A1 Dipropionamide A1 Dipropionamide 20 0. 5 0 0 0 50* 10 0. 25 0 0 0 20* Table 40 PPMAI Average Death % Expected Control Actual Control A1 Right Destroy A1 Right DeTaol 20 0. 5 0 0 0 50* 10 0. 25 0 0 0 20* 64 201138631 Table 41 PPMAI A1 Compound ΠΙ A1 Average Death % Compound m Expected Control Actual Control 20 0. 5 0 100 100 70 10 0. 25 0 100 100 70 5 0. 125 0 90 90 50 2. 5 0. 0625 0 70 70 50 1. 25 0. 03125 0 20 20 20 0. 625 0. 015625 0 20 20 20 20 1 0 100 100 70 10 0. 5 0 100 100 70 5 0. 25 0 100 100 70 2. 5 0. 125 0 90 90 70 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 20 20 20 0. 3125 0. 015625 0 20 20 0 20 2 0 100 100 90 10 1 0 100 100 90 5 0. 5 0 100 100 90 2. 5 0. 25 0 100 100 90 1. 25 0. 125 0 90 90 90 0. 625 0. 0625 0 70 70 90* 0. 3125 0. 03125 0 20 20 70* 0. 15625 0. 015625 0 20 20 50* 0. 078125 0. 0078125 0 0 0 20* 0. 0390625 0. 00390625 0 0 0 20* 5 1 0 100 100 90 2. 5 0. 5 0 100 100 90 1. 25 0. 25 0 100 100 90 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 70 70 90* 0. 15625 0. 03125 0 20 20 90* 0. 078125 0. 015625 0 20 20 90* 0. 0390625 0. 0078125 0 0 0 90* 0. 3125 0. 125 0 90 90 100* 0. 15625 0. 0625 0 70 70 100* 0. 078125 0. 03125 0 20 20 100* 0. 0390625 0. 015625 0 20 20 100* 65 201138631 Table 42 PPMAI mean death % Expected control Actual control A1 Compound IV A1 Compound IV 20 0. 5 0 0 0 50* 10 0. 25 0 0 0 20* Table 43 PPMAI A5 Atomin A5 Average Death % Atomin Expected Control Actual Control 1. 25 0. 03125 0 100 100 90 0. 625 0. 015625 0 90 90 90 0. 3125 0. 015625 0 90 90 100* 0. 15625 0. 0078125 0 0 0 20* 0. 15625 0. 015625 0 90 90 100* 0. 078125 0. 0078125 0 0 0 20* 0. 078125 0. 015625 0 90 90 100* 0. 0390625 0. 0078125 0 0 0 20* 0. 0390625 0. 015625 0 90 90 100* Table 44 PPMAI Average Death % Expected Control Actual Control A5 Isopizami A5 Isopizami 20 0. 5 0 0 0 20* 20 1 0 0 0 50* Table 45 A5 PPMAI Tetraisophthalonitrile A5 Average Death % Tetrachloroisocyanide Expected Control Actual Control 20 0. 5 0 20 20 100* 10 0. 25 0 0 0 20* 20 1 0 100 100 100 10 0. 5 0 20 20 50* 5 0. 5 0 20 20 20 2. 5 0. 5 0 20 20 50* 1. 25 0. 5 0 20 20 90* 66 201138631 Table 46 PPMAI Average Death % Expected Control Actual Control A5 Ring Block A5 Ring Block.      20 0. 5 0 90 90 70 10 0. 25 0 20 20 20 10 0. 5 0 90 90 70 5 0. 25 0 20 20 20 5 0. 5 0 90 90 90 2. 5 0. 25 0 20 20 20 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 20 20 20 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 20 20 50* Table 47 PPMAI Average Death % Expected Control Actual Control A5 Waiting for Kerry A5 Waiting for Kelly 20 0. 5 0 0 0 20* 20 1 0 20 20 90* 20 2 0 90 90 90 10 1 0 20 20 20 10 2 0 90 90 90 5 1 0 20 20 50* 5 2 0 90 90 70 2. 5 1 0 20 20 50* 1. 25 0. 5 0 0 0 20* Table 48 PPMAI mean death % Expected control Actual control A5 Dipropionamide A5 Dipropionamide 20 0. 5 0 0 0 20* 20 1 0 0 0 20* Table 49 PPM AI Average Death % Expected Control Actual Control 67 201138631 A5 Right Destroy A5 Right Destroy 20 0. 5 0 0 0 20* 20 1 0 0 0 20* Table 50 PPMAI A5 Compound III A5 Average Death % Compound III Expected Control Actual Control 5 0. 125 0 90 90 90 2. 5 0. 0625 0 90 90 50 1. 25 0. 03125 0 50 50 20 2. 5 0. 125 0 90 90 100* 1. 25 0. 0625 0 90 90 70 0. 625 0. 03125 0 50 50 20.   0. 3125 0. 015625 0 0 0 0 0. 15625 0. 0078125 0 0 0 0 0. 078125 0. 00390625 0 0 0 0 1. 25 0. 125 0 90 90 100* 0. 625 0. 0625 0 90 90 90 0. 3125 0. 03125 0 50 50 20 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 90 90 90 0. 15625 0. 03125 0 50 50 50 0. 3125 0. 125 0 90 90 100* 0. 15625 0. 0625 0 90 90 100* 0. 078125 0. 03125 0 50 50 50 0. 0390625 0. 015625 0 0 0 0 Table 51 A5 PPMAI Compound IV A5 Average Death % Compound IV Expected Control Actual Control 20 0. 5 0 0 0 20* 20 1 0 0 0 20* 10 0. 5 0 0 0 20* Table 52 PPMAI mean death % | expected control | actual control 68 201138631 A6 Atomin A6 Atomin 20 0. 5 0 90 90 90 10 0. 25 0 70 70 70 5 0. 125 0 70 70 50 2. 5 0. 0625 0 50 50 20 1. 25 0. 03125 0 50 50 20 0. 625 0. 015625 0 50 50 20 0. 3125 0. 0078125 0 20 20 20 0. 15625 0. 00390625 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 90 90 90 5 0. 25 0 70 70 70 2. 5 0. 125 0 70 70 50 1. 25 0. 0625 0 50 50 50 0. 625 0. 03125 0 50 50 50 0. 3125 0. 015625 0 50 50 50 0. 15625 0. 0078125 0 20 20 20 0. 078125 0. 00390625 0 20 20 20 20 2 0 90 90 90 10 1 0 90 90 ' 90 5 0. 5 0 90 90 90 2. 5 0. 25 0 70 70 50 1. 25 0. 125 0 70 70 50 0. 625 0. 0625 0 50 50 50 0. 3125 0. 03125 0 50 50 50 0. 15625 0. 015625 0 50 50 50 0. 078125 0. 0078125 0 20 20 20 0. 0390625 0. 00390625 0 20 20 20 10 2 0 90 90 90 5 1 0 90 90 90 2. 5 0. 5 0 90 90 70 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 70 70 50 0. 3125 0. 0625 0 50 50 50 0. 15625 0. 03125 0 50 50 50 0. 078125 0. 015625 0 50 50 50 0. 0390625 0. 0078125 0 20 20 50* 5 2 〇 90 90 90 69 201138631 2. 5 1 0 90 90 70 1. 25 0. 5 0 90 90 70 0. 625 0. 25 0 70 70 70 0. 3125 0. 125 0 70 70 70 0. 15625 0. 0625 0 50 50 50 0. 078125 0. 03125 0 50 50 50 0. 0390625 0. 015625 0 50 50 50 Table 53 A6 PPMAI Iso-Pezime A6 Average Death % Iso-Pakisto Expected Control Actual Control 20 1 0 20 20 20 20 2 0 50 50 20 10 1 0 20 20 20 10 2 0 50 50 20 5 1 0 20 20 0 5 2 0 50 50 50 2. 5 1 0 20 20 0 Table 54 A6 PPMAI Tetraisophthalonitrile A6 Average death % Tetraisophthalonitrile Expected control Actual control 20 0. 5 0 50 50 70* 10 0. 25 0 0 0 20* 20 1 0 90 90 100* 10 0. 5 0 50 50 70* 10 1 0 90 90 90 5 0. 5 0 50 50 20 5 1 0 90 90 100* 2. 5 0. 5 0 50 50 70* 5 2 0 100 100 100 2. 5 1 0 90 90 90 1. 25 0. 5 0 50 50 50 Table 55 PPMAI Average Death % Expected Control Actual Control A6 Ring Block A6 Ring Block 70 201138631 20 0. 5 0 50 50 50 20 1 0 70 70 70 10 0. 5 0 50 50 50 20 2 0 90 90 90 10 1 0 70 70 70 5 0. 5 0 50 50 50 10 2 0 90 90 90 5 1 0 70 70 70 2. 5 0. 5 0 50 50 50 5 2 0 90 90 90 2. 5 1 0 70 70 70 1. 25 0. 5 0 50 50 50 Table 56 PPMAI Mean Death % Expected Control Actual Control A6 Dipropionin A6 Dipropionamide 20 1 0 0 -0 70* Table 57 PPMAI A6 Compound ΠΙ A6 Average Death % Compound m Expected Control the actual control 2. 5 0. 0625 0 90 90 90 1. 25 0. 03125 0 50 50 50 1. 25 0. 0625 0 90 90 90 0. 625 0. 03125 0 50 50 50 0. 625 0. 0625 0 90 90 90 0. 3125 0. 03125 0 50 50 50 0. 3125 0. 0625 0 90 90 90 0. 15625 0. 03125 0 50 50 70* 0. 15625 0. 0625 0 90 90 90 0. 078125 0. 03125 0 50 50 70* 0. 0390625 0. 015625 0 0 0 20* Table 58 PPMAI Mean Death % Actual Control Expected Control A6 Compound IV A6 Compound IV 20 1 0 0 0 70* 71 201138631 Table 59 PPMAI A8 Atomin A8 Average Death % Atomin Expected Control Actual Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 70* 5 0. 125 0 50 50 70* 2. 5 0. 0625 0 50 50 50 1. 25 0. 03125 0 50 50 50 0. 625 0. 015625 0 50 50 50 0. 3125 0. 0078125 0 50 50 20 0. 15625 0. 00390625 0 20 20 0 20 1 0 70 70 90* 10 0. 5 0 70 70 70 5 0. 25 0 50 50 70* 2. 5 0. 125 0 50 50 70* 1. 25 0. 0625 0 50 50 50 0. 625 0. 03125 0 50 50 50 0. 3125 0. 015625 0 50 50 50 0. 15625 0. 0078125 0 50 50 20 0. 078125 0. 00390625 0 20 20 0 20 2 0 90 90 90 10 1 0 70 70 70 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 70* 1. 25 0. 125 0 50 50 70* 0. 625 0. 0625 0 50 50 50 0. 3125 0. 03125 0 50 50 50 0. 15625 0. 015625 0 50 50 50 0. 078125 0. 0078125 0 50 50 20 · 0. 0390625 0. 00390625 0 20 20 0 10 2 0 90 90 90 5 1 0 70 70 70 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 50 50 50 0. 15625 0. 03125 0 50 50 50 0. 078125 0. 015625 0 50 50 50 0. 0390625 0. 0078125 0 50 50 20 5 2 0 90 90 90 2. 5 1 0 70 70 70 72 201138631 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 70* 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 50 50 50 0. 078125 0. 03125 0 50 50 50 0. 0390625 0. 015625 0 50 50 50 Table 60 A8 PPMAI Tetrachloroisocyanonitrile A8 Average death % Tetrachloroisocyanonitrile Expected control Actual control 20 1 0 70 70 70 10 1 0 70 70 70 5 1 0 70 70 70 2. 5 0. 5 0 0 0 20* 2. 5 1 0 70 70 70 1. 25 0. 5 0 0 0 20* Table 61 A8 PPMAI Ring Block A8 Average Death % Loop Block Expected Control Actual Control 20 0. 5 0 50 50 50 20 1 0 90 90 90 10 0. 5 0 50 50 50 20 2 0 90 90 90 10 1 0 90 90 .  90 5 0. 5 0 50 50 50 10 2 0 90 90 90 5 1 0 90 90 90 2. 5 0. 5 0 50 50 50 5 2 0 90 90 90 2. 5 1 0 90 90 90 1. 25 0. 5 0 50 50 50 Table 62 PPMAI mean death % Expected control Actual control A8 Compound ΙΠ A8 Compound ΙΠ 2. 5 0. 0625 0 90 90 90 1. 25 0. 03125 0 70 70 50 73 201138631 0. 625 0. 015625 0 20 20 20 1. 25 0. 0625 0 90 90 90 0. 625 0. 03125 0 70 70 50 0. 3125 0. 015625 0 20 20 0 0. 625 0. 0625 0 90 90 90 0. 3125 0. 03125 0 70 70 50 0. 15625 0. 015625 0 20 20 0 0. 3125 0. 0625 0 90 90 90 0. 15625 0. 03125 0 70 70 50 0. 078125 0. 015625 0 20 20 20 0. 15625 0. 0625 0 90 90 100* 0. 078125 0. 03125 0 70 70 70 0. 0390625 0. 015625 0 20 20 50* Snowy blight Sexuality: Microdochium nivale, Fusarium nivale, Snow mould, Root rot: Will be taken from The spores of the fungi stored at low temperature are directly mixed in the nutrient medium (potato glucose broth). After the (DMSO) solution of the test compound was placed in a microtiter plate (96-well format), a nutrient medium containing fungal spores was added. The test plates were incubated at 24 ° C and the inhibition of growth was measured spectrophotometrically at 620 nm 72 hours after application. The application rates are as shown in the table: Table 63 PPMAI mean death % Expected control observed A1 Atomin A1 Atomin Control 1. 25 0. 03125 0 90 90 100* 0. 625 0. 015625 0 50 50 70* 0. 3125 0. 0078125 0 20 20 20 0. 625 0. 03125 0 90 90 100* 0. 3125 0. 015625 0 50 50 50 0. 15625 0. 0078125 0 20 20 20 74 201138631 0. 3125 0. 03125 0 90 90 100* 0. 15625 0. 015625 0 50 50 50 0. 078125 0. 0078125 0 20 20 20 0. 15625 0. 03125 0 90 90 100* 0. 078125 0. 015625 0 50 50 90* 0. 0390625 0. 0078125 0 20 20 50* 0. 078125 0. 03125 0 90 90 100* 0. 0390625 0. 015625 0 50 50 100* Table 64 PPMAI Average Death % Expected Control Observed A1 Isopipezami A1 Isopipezam Control 20 0. 5 0 0 0 20* 10 0. 25 0 0 0 20* Table 65 A1 PPMAI Tetraisophthalonitrile A1 Average Death % Tetraisophthalonitrile Expected Control Observed • Control 20 0. 5 0 70 70 100* 10 0. 25 0 0 0 50* 10 0. 5 0 70 70 100* 5 0. 5 0 70 70 100* 2. 5 0. 5 0 70 70 100* 1. 25 0. 5 0 70 70 100** Table 66 A1 PPMAI to Klee A1 Average Death % to Klee Expected Control Observed Control 20 0. 5 0 0 0 20* 20 1 0 20 20 0 20 2 0 100 100 90 10 1 0 20 20 0 10 2 0 100 100 50 5 1 0 20 20 0 5 2 0 100 100 100 2. 5 1 0 20 20 20 Table 67 75 201138631 PPMAI Average Death % Expected Control Observed A1 Dipropionamide A1 Dipropionamide Control 20 0. 5 0 0 0 20* 10 0. 25 0 0 0 20* Table 68 PPMAI Average Death % Expected Control Observed A1 Right Destroy A1 Right Destroy Control 20 0. 5 0 0 0 20* 10 0. 25 0 0 0 20* Table 69 PPMAI Ai Compound m A1 Average Death % Compound ΙΠ Expected Control Observed Control 20 0. 5 0 90 90 100* 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 10 0. 5 ' 0 90 90 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 5 0. 5 0 90 90 90 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 50 50 70* 0. 625 0. 125 0 20 20 50* 0. 3125 0. 0625 0 0 0 50* 0. 15625 0. 03125 0 0 0 20* 0. 078125 0. 015625 0 0 0 20* 1. 25 0. 5 0 90 90 100* 0. 625 0. 25 0 50 50 100* 0. 3125 0. 125 0 20 20 90* 0. 15625 0. 0625 0 0 0 50* 0. 078125 0. 03125 0 . 0 0 50* 0. 0390625 0. 015625 0 0 0 50* Table 70 76 201138631 A1 PPMAI Compound IV A1 Mean Death % Compound IV Expected Control Observed Control 20 0. 5 0 0 0 20* 20 2 0 50 50 20 10 2 0 50 50 20 5 2 0 50 50 50 Table 71 PPMAI mean death % expected control observed A5 Atomin A5 Atomin Control 0. 3125 0. 0078125 0 70 70 90* 0. 15625 0. 00390625 0 0 0 0 0. 15625 0. 0078125 0 70 70 70 0. 078125 0. 0078125 0 70 70 70 0. 0390625 0. 0078125 0 70 70 70 Table 72 • PPMAI Average Death % Expected Control Observed A5 Waiting for Kerry A5 Waiting for Klee Control 5 1 0 0 0 20* 2. 5 1 0 0 0 20* Table 73 A5 PPMAI Compound in A5 Average Death % Compound m Expected Control Observed Control 20 0. 5 0 90 90 100* 10 0. 25 0 50 50 20 10 0. 5 0 90 90 100* 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 5 0. 5 0 90 90 100* 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 0 2. 5 0. 5 0 90 90 100* 1. 25 0. 25 0 50 50 70* 0. 625 0. 125 0 20 20 0 77 201138631 1. 25 0. 5 0 90 90 100* 0. 625 0. 25 0 50 50 90* 0. 3125 0. 125 0 20 20 0 Table 74 A5 PPMAI Compound IV A5 Average Death % Compound IV Expected Control Observed Control 20 2 0 50 50 20 10 2 0 50 50 20 5 2 0 50 50 20 Table 75 A6 PPMAI Atomin A6 Mean Death % Controlled by the expected control of Atomin 0. 625 0. 015625 0 90 90 90 0. 3125 0. 0078125 0 20 20 20 0. 3125 0. 015625 0 90 90 90 0. 15625 0. 0078125 0 20 20 20 0. 078125 0. 00390625 0 0 0 0 0. 15625 0. 015625 0 90 90 90 0. 078125 0. 0078125 0 20 20 20 0. 078125 0. 015625 0 90 90 90 0. 0390625 0. 0078125 0 20 20 20 0. 0390625 0. 015625 0 90 90 90 Table 76 A6 PPMAI Iso-Pezime A6 Average Death % Iso-Pezami Expected Control Observed Control 20 0. 5 0 20 20 20 10 0. 25 0 0 0 20* 20 1 0 50 50 50 10 0. 5 0 20 20 20 10 1 0 50 50 50 5 0. 5 0 20 20 20 5 1 0 50 50 50 2. 5 0. 5 0 20 20 20 2. 5 1 0 50 50 50 78 201138631 1 1. 25 0. 5 0 20 20 20 Table 77 PPMAI mean death % expected control observed A6 tetrachloroisophthalonitrile A6 four gas isophthalonitrile control 10 0. 25 0 20 20 20 5 0. 25 0 20 20 20 2. 5 0. 25 0 20 20 20 1. 25 0. 25 0 20 20 20 0. 625 0. 25 0 20 20 20 Table 78 PPMAI Average Death % Expected Control Observed A6 Waiting for Kerry A6 Waiting for Klee Control 20 0. 5 0 0 0 20* 20 1 0 50 50 50 10 1 0 50 50 50 5 1 0 50 50 50 2. 5 1 0 50 50 50 Table 79 A6 PPMAI Compound m A6 Mean Death % Compound m Expected Control Observed Control 20 0. 5 0 90 90 100* 10 0. 25 0 70 70 70 5 0. 125 0 50 50 20 2. 5 0. 0625 0 20 20 0 10 0. 5 0 90 90 100* 5 0. 25 0 70 70 70 2. 5 0. 125 0 50 50 20 1. 25 0. 0625 0 20 20 0 5 0. 5 0 90 90 100* 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 2. 5 0. 5 0 90 90 100 1. 25 0. 25 0 70 70 70 79 201138631 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 1. 25 0. 5 0 90 90 100* 0. 625 0. 25 0 70 70 90* 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 Table 80 A6 PPM AI Compound IV A6 Mean Death % Compound IV Expected Control Observed Control 20 1 0 20 20 20 20 2 0 70 70 50 10 1 0 20 20 20 10 2 0 70 70 70 5 1 0 20 20 20 5 2 0 70 70 70 2. 5 1 0 20 20 20 Table 81 PPMAI A8 Atomin A8 Average Death % Atomin Expected Control Observed Control 0. 625 0. 015625 0 90 90 90 0. 3125 0. 0078125 0 20 20 20 0. 15625 0. 00390625 0 20 20 0 0. 3125 0. 015625 0 90 90 90 0. 15625 0. 0078125 0 20 20 20 0. 078125 0. 00390625 0 20 20 0 0. 15625 0. 015625 0 90 90 50 0. 078125 0. 0078125 0 20 20 20 0. 0390625 0. 00390625 0 20 20 0 0. 078125 0. 015625 0 90 90 90 0. 0390625 0. 0078125 0 20 20 20 0. 0390625 0. 015625 0 90 90 90 Table 82 PPMAI mean death % expected control observed A8 isopipezamine A8 isopipezide control 80 201138631 20 1 0 20 20 0 20 2 0 20 20 0 10 1 . 0 20 20 0 10 2 0 20 20 0 5 1 0 20 20 0 5 2 0 20 20 0 2. 5 1 0 20 20 0 Table 83 A8 PPM AI Tetraisophthalonitrile A8 Average Death % Tetraisophthalonitrile Expected Control Observed Control 10 0. 25 0 50 50 20 5 0. 25 0 50 50 20 2. 5 0. 25 0 50 50 20 1. 25 0. 25 0 50 50 20 0. 625 0. 25 0 50 50 20 Table 84 A8 PPMAI to Klee A8 Average Death % to Klee Expected Control Observed Control 20 1 0 50 50 20 10 1 0 50 50 20 5 1 0 50 50 20 2. 5 1 0 50 50 50 Table 85 A8 PPMAI Compound III A8 Average Death % Compound 预期 Expected Control Observed Control 10 0. 25 0 70 70 70 5 0. 125 0 50 50 20 2. 5 0. 0625 0 20 20 0 5 0. 25 0 70 70 70 2. 5 0. 125 0 50 50 20 1. 25 0. 0625 0 20 20 0 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 81 201138631 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 0. 625 0. 25 0 70 70 70 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 Table 86 A8 PPMAI Compound IV A8 Average Death % Compound IV Expected Control Observed Control 20 1 0 20 20 20 20 2 0 70 70 70 10 1 0 20 20 20 10 2 0 70 70 70 5 1 0 20 20 20 5 2 0 70 70 70 . 2. 5 1 0 20 20 20 Gray mold: Spores from fungi stored in low temperature are directly mixed in nutrient medium (potato glucose medium). After the (DMSO) solution of the test compound is placed in a microtiter plate (96-well format), a nutrient medium containing fungal spores is added. The test discs were cultured at 24 ° C and the inhibition of growth was measured by a luminometer 72 hours after the application. The application rates are as shown in the table: Table 87 A1 PPM AI Atropin A1 Mean Death % Atomione Expected Control 1 Observed Control 20 0. 5 0 20 20 20 10 0. 25 0 0 0 20* 20 1 0 20 20 20 10 0. 5 0 20 20 20 20 2 0 20 20 20 82 201138631 10 1 0 20 20 20 5 0. 5 0 20 20 20 10 2 0 20 20 20 5 1 0 20 20 20 2. 5 0. 5 0 20 20 0 5 2 0 20 20 20 2. 5 1 0 20 20 20 1. 25 0. 5 0 20 20 20 Table 88 PPMAI A1 Iso-Pezime A1 Average Death % Iso-Pezami Expected Control Observed Control 20 0. 5 0 50 50 50 10 0. 25 0 50 50 50 5 0. 125 0 50 50 50 2. 5 0. 0625 0 50 50 20 1. 25 0. 03125 0 20 20 20 0. 625 0. 015625 0 20 20 20 0. 3125 0. 0078125 0 20 20 0 20 1 0 70 70 70 10 0. 5 0 50 50 50 5 0. 25 0 50 50 50 2. 5 0. 125 0 50 50 20 1. 25 0. 0625 0 50 50 20 0. 625 0. 03125 0 20 20 20 0. 3125 0. 015625 0 20 20 20 20 2 0 90 90 90 10 1 0 70 70 70 5 0. 5 0 50 50 50 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 50 50 20 0. 3125 0. 03125 0 20 20 20 0. 15625 0. 015625 0 20 20 20 0. 078125 0. 0078125 0 20 20 20 0. 0390625 0. 00390625 0 0 0 20* 10 2 0 90 90 90 5 1 0 70 70 70 2. 5 0. 5 0 50 50 50 83 201138631 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 50 50 20 0. 3125 0. 0625 0 50 50 20 0. 15625 0. 03125 0 20 20 20 0. 078125 0. 015625 0 20 20 20 0. 0390625 0. 0078125 0 20 20 20 5 2 0 90 90 90 2. 5 1 0 70 70 70 1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 50 50 20 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 20 20 20 Table 89 A1 PPMAI Tetraisophthalonitrile A1 Average Death % Tetraisophthalonitrile Expected Control Observed Control 20 0. 5 0 0 0 0 10 0. 5 0 0 0 20* 5 0. 5 0 0 0 20* 2. 5 0. 5 0 0 0 20* 1. 25 0. 5 0 0 0 20* Table 90 A1 PPMAI Loop Block A1 Average Death % Loop Block Expected Control Observed Control 20 0. 5 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 20 20 20 10 1 0 90 90 100* 5 0. 5 0 20 20 20 5 1 0 90 90 100* 2. 5 0. 5 0 20 20 20 2. 5 1 0 90 90 100* 1. 25 0. 5 0 20 20 20 Table 91 84 201138631 A1 PPMAI Waiting for Klein A1 Average Death % Controlled by Klee Expected Control 20 1 0 90 90 50 20 2 0 100 100 90 10 1 0 90 90 50 5 1 0 90 90 50 2 . 5 1 0 90 90 70 1. 25 0. 5 0 0 0 20* Table 92 PPMAI A1 Compound ΙΠ A1 Average Death % Compound m Expected Control Observed Control 20 0. 5 0 50 50 50 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 20 20 20 20 1 0 70 70 70 10 0. 5 0 50 50 50 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 1. 25 0. 0625 0 20 20 20 0. 625 0. 03125 0 20 20 20 20 2 0 90 90 90 10 1 0 70 70 70 5 0. 5 0 50 50 50 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 20 20 20 10 2 0 90 90 90 5 1 0 70 70 70 2. 5 0. 5 0 50 50 50 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 20 20 50* 0. 3125 0. 0625 0 20 20 20 0. 15625 0. 03125 0 20 20 20 0. 078125 0. 015625 0 0 0 20* 85 201138631 0. 0390625 0. 0078125 0 0 0 20* 5 2 0 90 90 90 2. 5 1 0 70 70 70 1. 25 0. 5 0 50 50 70* 0. 625 0. 25 0 50 50 70* 0. 3125 0. 125 0 20 20 70* 0. 15625 0. 0625 0 20 20 50* 0. 078125 0. 03125 0 20 20 50* 0. 0390625 0. 015625 0 0 0 50* Table 93 A1 PPMAI Compound IV A1 Average Death % Compound IV Expected Control Observed Control 20 0. 5 0 50 50 50 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 2. 5 0. 0625 0 20 20 20 20 1 0 50 50 50 10 0. 5 0 50 50 50 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 1. 25 0. 0625 0 20 20 20 20 2 0 70 70 70 10 1 0 50 50 50 5 0. 5 0 50 50 50 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 0. 625 0. 0625 0 20 20 20 10 2 0 70 70 70 5 1 0 50 50 50 2. 5 0. 5 0 50 50 50 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 20 20 20 0. 3125 0. 0625 0 20 20 0 5 2 0 70 70 ne 2. 5 1 0 50 50 ne 1. 25 0. 5 0 50 50 ne 0. 625 0. 25 0 50 50 ne 0. 3125 0. 125 0 20 20 50* 86 201138631 0. 15625 0. 0625 0 20 20 20 0. 078125 0. 03125 0 0 0 20* Table 94 A5 PPMAI Atomin A5 Average Death % Atomione Expected Control Observed Control 20 0. 5 0 50 50 50 20 1 0 50 50 50 10 0. 5 0 50 50 50 20 2 0 50 50 50 10 1 0 50 50 50 5 0. 5 0 50 50 50 10 2 0 50 50 70* 5 1 0 50 50 50 2. 5 0. 5 0 50 50 50 5 2 0 50 50 70* 2. 5 1 0 50 50 50 1. 25 0. 5 0 50 50 50 Table 95 A5 PPMAI Iso-Pezime A5 Average Death % Iso-Pezami Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 20 20 20 0. 625 0. 015625 0 0 0 20* 20 1 0 90 90 90 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 0. 625 0. 03125 0 20 20 20 0. 3125 0. 015625 0 0 0 20* 10 1 0 90 90 90 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 50 87 201138631 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 20 20 20 5 1 0 90 90 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 0. 15625 0. 03125 0 20 20 20 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 0 0 20* Table 96 A5 PPMAI Tetraisophthalonitrile A5 Mean Death % Tetraisophthalonitrile Expected Control Observed Control 10 0. 25 0 '50 50 50 5 0. 25 0 50 50 50 2. 5 0. 25 0 50 50 50 1. 25 0. 25 0 50 50 70* 0. 625 0. 25 0 50 50 70* 0. 3125 0. 125 0 0 0 20* Table 97 A5 PPMAI Loop Block A5 Average Death % Loop Block Expected Control Observed Control 20 0. 5 0 20 20 20 20 1 0 100 100 90 10 0. 5 0 20 20 20 10 1 0 100 100 90 5 0. 5 0 20 20 . 20 5 1 0 100 100 90 2. 5 0. 5 0 20 20 20 2. 5 1 0 100 100 90 88 201138631 1 1. 25 0. 5 0 20 20 20 Table 98 PPMAI mean death % Expected observed A5 Waiting Klee A5 Kelly Control Control 20 0. 5 . 0 20 20 0 20 1 0 90 90 90 10 0. 5 0 20 20 20 10 1 0 90 90 90 5 0. 5 0 20 20 50* 5 1 0 90 90 100* 2. 5 0. 5 0 20 20 50* 2. 5 1 0 90 90 100* 1. 25 0. 5 0 20 20 50* Table 99 A5 PPMAI Compound ΙΠ A5 Average Death % Compound 预期 Expected Control Observed Control 20 0. 5 0 90 90 90 10 0. 25 0 70 70 70 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 20 20 20 0. 625 0. 015625 0 20 20 20 10 0. 5 0 90 90 90 5 0. 25 0 70 70 70 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 50* 0. 625 0. 03125 0 20 20 20 0. 3125 0. 015625 0 20 20 20 5 0. 5 0 90 90 90 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 20 20 20 0. 15625 0. 015625 0 20 20 0 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 50 50 50 89 201138631 0. 3125 0. 0625 0 20 20 50* 0. 15625 0. 03125 0 20 20 20 0. 078125 0. 015625 0 20 20 20 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 70 70 70 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 50* 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 20 20 20 Table 100 A5 PPMAI Compound IV A5 Average Death % Compound IV Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 2. 5 0. 0625 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 1. 25 0. 0625 0 20 20 20 10 1 0 90 90 90 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 0. 625 0. 0625 0 20 20 20 5 1 0 90 90 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 20 20 20 0. 3125 0. 0625 0 20 20 20 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 20 20 20 0. 15625 0. 0625 0 20 20 20 Table 101 90 201138631 A6 PPMAI Atomin A6 Average Death % Atomin Expected Control Observed Control 20 0. 5 0 50 50 50 10 0. 25 0 20 20 20 20 1 0 50 50 50 10 0. 5 0 50 50 50 5 0. 25 0 20 20 20 20 2 0 50 50 50 10 1 0 50 50 50 5 0. 5 0 50 50 50 2. 5 0. 25 0 20 20 20 10 2 0 50 50 50 5 1 0 50 50 50 2. 5 0. 5 0 50 50 50 1. 25 0. 25 0 20 20 20 5 2 0 50 50 50 2. 5 1 0 50 50 50 1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 20 20 20 Table 102 A6 PPMAI Iso-Pezime A6 Average Death % Iso-Pezami Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 20 20 20 0. 625 0. 015625 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 0. 625 0. 03125 0 20 20 20 0. 3125 0. 015625 0 20 20 20 10 1 0 90 90 90 5 0. 5 0 70 70 70 91 201138631 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 20 20 20 0. 15625 0. 015625 0 20 20 20 5 1 0 90 90 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 . 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 0. 15625 0. 03125 0 20 20 20 0. 078125 0. 015625 0 20 20 20 0. 0390625 0. 0078125 0 0 0 20* 5 2 0 100 100 90 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 20 20 20 Table 103 A6 PPMAI Tetrachloroisocyanonitrile A6 Average death % Tetrachloroisocyanide Expected Control Observed Control 10 0. 25 0 50 50 50 5 0. 25 0 50 50 50 2. 5 0. 25 0 50 50 50 1. 25 0. 25 0 50 50 50 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 0 0 20* Table 104 PPMAI mean death % Expected observed A6 ring block A6 ring block control Control 20 0. 5 0 50 50 20 10 0. 5 0 50 50 20 5 0. 5 0 50 50 20 92 201138631 2. 5 0. 5 0 50 50 20 1. 25 0. 5 0 50 50 50 Table 105 A6 PPMAI Waiting for Klee A6 Average Death % to Klee Expected Control Observed Control 20 0. 5 0 50 50 50 10 0. 25 0 0 0 . 20* 20 1 0 90 90 100* 10 0. 5 0 50 50 50 10 1 0 90 90 100* 5 0. 5 0 50 50 50 5 1 0 90 90 100* 2. 5 0. 5 0 50 50 50 2. 5 1 0 90 90 100* 1. 25 0. 5 0 50 50 50 Table 106 A6 PPMAI Compound m A6 Average Death % Compound 预期 Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 0. 625 0. 03125 0 20 20 20 10 1 0 90 90 90 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 70* 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 20 20 20 5 1 0 90 90 90 93 201138631 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 0. 15625 0. 03125 0 20 20 20 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 0 0 20* Table 107 A6 PPMAI Compound IV A6 Average Death % Compound IV Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 2. 5 0. 0625 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 1. 25 0. 0625 0 20 20 20 10 1 0 90 90 90 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 0. 625 0. 0625 0 20 20 0 5 1 0 90 90 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 20 20 20 0. 3125 0. 0625 0 20 20 20 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 20 20 20 94 201138631 0. 15625 0. 0625 0 20 20 20 Table 108 A8 PPMAI Atomin A8 Average Death % Atomin Expected Control Observed Control 20 0. 5 0 50 50 50 10 0. 25 0 20 20 20 20 1 0 50 50 50 10 0. 5 0 50 50 50 5 0. 25 0 20 20 20 20 2 0 50 50 50 10 1 0 50 50 50 5 0. 5 0 50 50 50 2. 5 0. 25 0 20 20 20 10 2 0 50 50 50 5 1 0 50 50 50 2. 5 0. 5 0 50 50 50 1. 25 0. 25 0 20 20 20 5 2 0 50 50 50 2. 5 1 0 50 50 50 1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 20 20 20 Table 109 A8 PPMAI Iso-Pezime A8 Average Death % Different Zhamei Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 20 20 20 0. 625 0. 015625 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 0. 625 0. 03125 0 20 20 20 95 201138631 0. 3125 0. 015625 0 20 20 20 10 1 0 90 90 90 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 20 20 20 0. 15625 0. 015625 0 20 20 20 5 1 0 90 90 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 0. 15625 0. 03125 0 20 20 20 0. 078125 0. 015625 0 20 20 20 0. 0390625 0. 0078125 0 0 0 20* 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 20 20 20 Table 110 A8 PPMAI Tetraisophthalonitrile A8 Average Death % Tetraisophthalonitrile Expected Control Observed Control 5 0. 125 0 20 20 50* 2. 5 0. 125 0 20 20 50* 1. 25 0. 125 0 20 20 50* 0. 625 0. 125 0 20 20 20 0. 3125 0. 125 0 20 20 20 Table 111 PPMAI mean death % Expected observed A8 ring block A8 ring block control Control 20 0. 5 0 20 20 20 10 0. 5 0 20 20 20 96 201138631 5 0. 5 0 20 20 20 2. 5 0. 5 0 20 20 20 1. 25 0. 5 0 20 20 20 Table 112 A8 PPMAI to Klee A8 Average Death % to Klee Expected Control Observed Control 20 0. 5 0 50 50 50 10 0. 25 0 0 0 20* 20 1 0 90 90 90 10 0. 5 0 50 50 50 10 1 0 90 90 90 5 0. 5 0 50 50 50 5 1 0 90 90 100* 2. 5 0. 5 0 50 50 50 2. 5 1 0 90 90 100* 1. 25 0. 5 0 50 50 50 Table 113 A8 PPMAI Compound III A8 Average death % Compound m Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 20 20 20 0. 625 0. 015625 0 20 20 20 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 0. 625 0. 03125 0 20 20 20 0. 3125 0. 015625 0 20 20 20 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 20 20 20 97 201138631 0. 15625 0. 015625 0 20 20 20 5 1 0 100 100 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 0. 15625 0. 03125 0 20 20 20 0. 078125 0. 015625 0 20 20 20 2. 5 1 0 100 100 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 0. 078125 0. 03125 0 20 20 20 0. 0390625 0. 015625 0 20 20 20 Table 114 A8 PPMAI Compound IV A8 Average Death % Compound IV Expected Control Observed Control 20 0. 5 0 70 70 70 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 2. 5 0. 0625 0 20 20 20 1. 25 0. 03125 0 0 0 20* 20 1 0 90 90 90 10 0. 5 0 70 70 70 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 1. 25 0. 0625 0 20 20 20 0. 625 0. 03125 0 0 0 20* 10 1 0 90 90 90 5 0. 5 0 70 70 70 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 0. 625 0. 0625 0 20 20 20 0. 3125 0. 03125 0 0 0 20* 5 1 0 90 90 90 2. 5 0. 5 0 70 70 70 1. 25 0. 25 0 50 50 50 98 201138631 0. 625 0. 125 0 20 20 20 0. 3125 0. 0625 0 20 20 20 0. 15625 0. 03125 0 0 0 20* 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 20 20 20 0. 15625 0. 0625 0 20 20 20 0. 078125 0. 03125 0 0 0 20* Continued anthrax disease (Glomerella lagenarium) ("•syn.  /agenarz'wm), melon anthracnose · The spores of the fungus taken from low temperature storage are directly mixed in the nutrient medium (horse mash solution). After the (DMSO) solution of the test compound is placed in a microtiter plate (96-well format), a nutrient medium containing fungal spores is added. The test discs were incubated at 24 ° C and the inhibition of growth was measured spectrophotometer at 620 nm 72 hours after application. The application rates are as shown in the table: Table 115 PPMAI mean death % Expected observed A1 Atomin A1 Atomin Control Control 1. 25 0. 03125 0 50 50 70* 0. 625 0. 015625 0 20 20 20 0. 625 0. 03125 0 50 50 70* 0. 3125 0. 015625 0 20 20 20 0. 3125 0. 03125 0 50 50 70* 0. 15625 0. 015625 0 20 20 20 0. 15625 0. 03125 0 50 50 70* 0. 078125 0. 015625 0 20 20 50* 0. 0390625 0. 0078125 0 0 0 20* 0. 078125 0. 03125 0 50 50 100* 99 201138631 10. 0390625 0. 015625 1 0_20 | 20 | 90* Table 116 A1 PPMAI Iso-Pezime A1 Average Death % Iso-Pakimei Expected Control Observed Control 20 2 0 50 50 0 10 2 0 50 50 0 5 2 0 50 50 20 Table 117 A1 PPMAI Four-gas isophthalonitrile A1 Average death % Four gas isophthalonitrile expected to control the observed control 20 0. 5 0 70 70 100* 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 10 0. 5 0 70 70 100* 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 5 0. 5 . 0 70 70 90* 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 2. 5 0. 5 0 70 70 100* 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 20 20 20 1. 25 0. 5 0 70 70 100* 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 20 20 20 Table 118 A1 PPMAI to Klee A1 Average Death % to Klee Expected Control Observed Control 20 0. 5 0 20 20 20 20 1 0 20 20 20 10 0. 5 0 20 20 20 20 2 0 50 50 50 10 1 0 20 20 20 5 0. 5 0 20 20 20 100 201138631 10 2 0 50 50 50 5 . 1 0 20 20 20 2. 5 0. 5 0 20 20 0 5 2 0 50 50 50 2. 5 1 0 20 20 20 1. 25 0. 5 0 20 20 20 Table 119 PPMAI A1 Compound ΙΠ A1 Average Death % Compound m Expected Control Observed Control 5 0. 125 0 50 50 100* 2. 5 0. 0625 0 20 20 50* 1. 25 0. 03125 0 0 0 20* 2. 5 0. 125 0 50 50 90* 1. 25 0. 0625 0 20 20 50* 0. 625 0. 03125 0 0 0 20* 1. 25 0. 125 0 50 50 90* 0. 625 0. 0625 0 20 20 50* 0. 3125 0. 03125 0 0 0 20* 0. 625 0. 125 0 50 50 100* 0. 3125 0. 0625 0 20 20 100* 0. 15625 0. 03125 0 0 0 100* 0. 078125 0. 015625 0 0 0 100* 0. 0390625 0. 0078125 0 0 0 90* 0. 3125 0. 125 0 50 50 100* 0. 15625 0. 0625 0 20 20 100* 0. 078125 0. 03125 0 0 0 100* 0. 0390625 0. 015625 0 0 0 100* Table 120 A5 PPMAI Azoystrobin Average Death % Expected 2. Observed 2. 5 0. 0625 0 70 70 90* 1. 25 0. 03125 0 50 50 50 0. 625 0. 015625 0 50 50 20 1. 25 0. 0625 0 70 70 90* 0. 625 0. 03125 0 50 50 50 0. 3125 0. 015625 0 50 50 20 101 201138631 0. 625 0. 0625 0 70 70 100* 0. 3125 0. 03125 0 50 50 90* 0. 15625 0. 015625 0 50 50 0 0. 3125 0. 0625 0 70 70 90* 0. 15625 0. 03125 0 50 50 70* 0. 078125 0. 015625 0 50 50 50 0. 0390625 0. 0078125 0 0 0 20* 0. 15625 0. 0625 0 70 70 90* 0. 078125 0. 03125 0 50 50 70* 0. 0390625 0. 015625 0 50 50 50 Table 121 PPMAI Mean Death % Expected observed A5 Isopipezamine A5 Isopipezide Control Control 10 2 0 20 20 50* 5 2 0 20 20 20 Table 122 A5 PPMAI Tetrachloroisocyanonitrile A5 Mean death % Four gas isophthalonitrile expected to control the observed control 10 0. 25 0 90 90 90 5 0. 125 0 50 50 50 5 0. 25 0 90 90 100* 2. 5 0. 125 0 50 50 50 2. 5 0. 25 0 90 90 100* 1. 25 0. 125 0 50 50 70* 1. 25 0. 25 0 90 90 100* 0. 625 0. 125 0 50 50 50 0. 625 0. 25 0 90 90 100* 0. 3125 0. 125 0 50 50 50 Table 123 PPMAI Mean Death % Expected observed A5 Waiting KL A5 Klee Control Control 20 1 0 20 20 20 20 2 0 50 50 50 10 1 0 20 20 20 102 201138631 10 2 0 50 50 50 5 1 0 20 20 20 5 2 0 50 50 50 2. 5 1 0 20 20 20 Table 124 A5 PPMAI Compound m A5 Average Death % Compound 预期 Expected Control Observed Control 2. 5 0. 0625 0 100 100 70 1. 25 0. 03125 0 20 20 20 1. 25 0. 0625 0 100 100 90 0. 625 0. 03125 0 20 20 20 0. 625 0. 0625 0 100 100 90 0. 3125 0. 03125 0 20 20 20 0. 3125 0. 0625 0 100 100 90 0. 15625 0. 03125 0 20 20 0 0. 15625 0. 0625 0 100 100 90 0. 078125 0. 03125 0 20 20 20 Table 125 PPMAI Mean Death % Expected observed A6 Isopipeza A6 Isopipezide Control Control 20 2 0 20 20 20 10 2 0 20 20 20 2 0 20 20 20 Table 126 A6 PPMAI Klee A6 Average Death % Controlled by Klee Expected Control 20 1 0 20 20 20 20 2 0 20 20 20 10 1 0 20 20 20 10 2 0 20 20 0 5 1 0 20 20 0 5 2 0 20 20 50* 2. 5 1 0 20 20 0 Table 127 103 201138631 PPMAI Average Death % Expected Observed A6 Compound ΠΊ A6 Compound ΠΙ Control Control 0. 15625 0. 03125 0 0 ' 0 100* 0. 078125 0. 015625 0 0 0 20* 0. 15625 0. 0625 0 100 100 90 0. 078125 0. 03125 0 0 0 20* Table 128 PPMAI Mean Death % Expected observed A8 'Isipaziza A8 Isopipezide Control Control 20 2 0 20 20 20 10 2 0 20 20 20 2 0 20 20 20 Table 129 A8 PPMAI Tetraisophthalonitrile A8 Average Death % Four gas isophthalonitrile expected to control the observed control 10 0. 25 0 90 90 20 5 0. 25 0 90 90 50 2. 5 0. 25 0 90 90 100* 1. 25 0. 25 0 90 90 100* 0. 625 0. 25 0 90 90 70 Table 130 A8 PPMAI . Waiting for Klein A8 Average Death % Controlled by Klee Expected Control 20 1 0 20 20 0 20 2 0 20 20 20 10 1 0 20 20 0 10 2 0 20 20 20 5 1 0 20 20 0 5 2 20 20 20 20 2. 5 1 0 20 20 0 Table 131____ PPMAI average death % """~~| Observed 104 201138631 A8 Compound ΙΠ A8 Compound m Control Control 2. 5 0. 0625 0 70 70 100* '1. 25 0. 0625 0 70 70 70 0. 625 0. 0625 0 70 70 90* 0. 3125 0. 0625 0 70 70 50 0. 15625 0. 03125 0 0 0 20* 0. 15625 0. 0625 0 70 70 50 0. 078125 0. 03125 0 0 0 20* A. sylvestris irihcz·) (leaf blotch): Spores from fungi stored at low temperature are directly mixed in a nutrient medium (potato glucose broth). After the (DMS0) solution of the test compound was placed in a microtiter plate (96-well format), a nutrient medium containing fungal spores was added. The test plates were incubated at 24 ° C and the inhibition of growth was measured spectrophotometrically 72 hours after application. The application rate is not as shown in the table.  Table 132 PPMAI A1 Atomin A1 Average Death % Atomione Expected Control Observed Control 5 0. 125 0 90 90 100* 2. 5 0. 0625 0 70 70 90* 1. 25 0. 03125 0 50 50 50 0. 625 0. 015625 0 20 20 20 2. 5 0. 125 0 90 90 100* 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 50 50 50 0. 3125 0. 015625 0 20 20 20 1. 25 0. 125 0 90 90 90 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 50 50 50 105 201138631 0. 15625 0. 015625 0 20 20 20 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 70 70 70 0. 15625 0. 03125 0 50 50 50 .   0. 078125 0. 015625 0 20 20 50* 0. 0390625 0. 0078125 0 0 0 20* 0. 3125 0. 125 0 90 90 100* 0. 15625 0. 0625 0 70 70 90* 0. 078125 0. 03125 0 50 50 90* 0. 0390625 0. 015625 0 20 20 70* Table 133 PPMAI A1 Iso-Pezime A1 Average Death % Iso-Pezami Expected Control Observed Control 20 0. 5 0 90 90 100* 10 0. 25 0 70 70 90* 5 0. 125 0 50 50 90* 2. 5 0. 0625 0 20 20 50* 1. 25 0. 03125 0 0 0 20* 10 0. 5 0 90 90 90 5 0. 25 0 70 70 70 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 5 0. 5 0 90 90 90 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 50 50 70* 0. 3125 0. 0625 0 20 20 50* 0. 15625 0. 03125 0 0 0 20* 0. 078125 0. 015625 0 0 0 20* 0. 0390625 0. 0078125 0 0 0 20* 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 70 70 90* 0. 3125 0. 125 0 50 50 70* 0. 15625 0. 0625 0 20 20 50* 106 201138631 0. 078125 0. 03125 0 0 0 50* 0. 0390625 0. 015625 0 0 0 20* Table 134 A1 PPMAI Tetraisophthalonitrile A1 Average death % Four gas isophthalonitrile expected control observed control 20 1 0 70 70 100* 10 1 0 70 70 100* 5 1 0 70 70 100 * 2. 5 1 0 70 70 100* Table 135 A1 PPMAI Loop Block A1 Average Death % Loop Block Expected Control Observed Control 20 0. 5 0 50 50 70* 10 0. 25 0 0 0 50* 20 1 0 70 70 70 10 0. 5 0 50 50 50 5 0. 25 0 0 0 20* 20 2 0 70 70 70 10 1 0 70 70 70 5 0. 5 0 50 50 50 10 2 0 70 70 70 5 1 0 70 70 70 2. 5 0. 5 0 50 50 50 5 2 0 70 70 70 2. 5 1 0 70 70 70 .   1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 0 0 20* Table 136 A1 PPMAI to Klee A1 Average Death % to Klee Expected Control Observed Control 20 0. 5 0 90 90 90 10 0. 25 0 70 70 90* 5 0. 125 0 70 70 90* 2. 5 0. 0625 0 50 50 70* 107 201138631 1. 25 0. 03125 0 20 20 20 20 1 0 90 90 90 10 0. 5 0 90 90 90 5 0. 25 0 70 70 70 2. 5 0. 125 0 70 70 70 1. 25 0. 0625 0 50 50 50 0. 625 0. 03125 0 20 20 20 20 2 0 90 90 90 10 1 0 90 90 90 5 0. 5 0 90 90 90 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 70 70 70 0. 625 0. 0625 0 50 50 50 0. 3125 0. 03125 0 20 20 20 10 2 0 90 90 90 5 1 0 90 90 90 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 70 70 90* 0. 625 0. 125 0 70 70 90* 0. 3125 0. 0625 0 50 50 90* 0. 15625 0. 03125 0 20 20 70* 0. 078125 0. 015625 0 0 0 70* 0. 0390625 0. 0078125 0 0 0 50* 5 2 0 90 90 90 2. 5 1 0 90 90 90 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 70 70 90* 0. 3125 0. 125 0 70 70 90* 0. 15625 0. 0625 0 50 50 70* 0. 078125 0. 03125 0 20 20 70* 0. 0390625 0. 015625 0 0 0 70* Table 137 A1 PPMAI Compound ΠΙ A1 Average Death % Compound 预期 Expected Control Observed Control 20 0. 5 0 70 70 90* 10 0. 25 0 50 50 90* 5 0. 125 0 20 20 70* 2. 5 0. 0625 0 0 0 50* 108 201138631 1. 25 0. 03125 0 0 0 20* 20 1 0 90 90 100* 10 0. 5 0 70 70 90* 5 0. 25 0 50 50 70* 2. 5 0. 125 0 20 20 50* 1. 25 0. 0625 0 0 0 20* 10 1 0 90 90 100* 5 0. 5 0 70 70 90* 2. 5 0. 25 0 50 50 70* 1. 25 0. 125 0 20 20 50* 0. 625 0. 0625 0 0 0 20* 5 1 0 90 90 100* 2. 5 0. 5 0 70 70 90* 1. 25 0. 25 0 50 50 70* 0. 625 0. 125 0 20 20 70* 0. 3125 0. 0625 0 0 0 50* 0. 15625 0. 03125 0 0 0 20* 0. 078125 0. 015625 0 0 0 20* 0. 0390625 0. 0078125 0 0 0 20* 2. 5 1 0 90 90 90 1. 25 0. 5 0 70 70 90* 0. 625 0. 25 0 50 50 90* 0. 3125 0. 125 0 20 20 70* 0. 15625 0. 0625 0 0 0 70* 0. 078125 0. 03125 0 0 0 70* 0. 0390625 0. 015625 0 0 0 50* Table 138 A1 PPMAI Compound IV A1 Average Death % Compound IV Expected Control Observed Control 20 0. 5 0 90 90 100* 10 0. 25 0 70 70 90* 5 0. 125 0 50 50 70* 2. 5 0. 0625 0 20 20 20 10 0. 5 0 90 90 90 5 0. 25 0 70 70 90* 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 5 0. 5 0 90 90 90 109 201138631 2. 5 0. 25 0 70 70 90* 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 70 70 70 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 Table 139 PPM AI A5 Atomin A5 Average Death % Atomione Expected Control Observed Control 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 20 20 20 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 20 20 20 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 20 20 20 0. 3125 0. 0625 0 70 70 90* 0. 15625 0. 03125 0 20 20 20 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 20 20 20 Table 140 A5 PPMAI Iso-Pezime A5 Average Death % Iso-Pazami Expected Control Observed Control 10 0. 25 0 90 90 90 5 0. 125 0 20 20 50* 2. 5 0. 0625 0 20 20 20 5 0. 25 0 90 90 90 2. 5 0. 125 0 20 20 20 1. 25 0. 0625 0 20 20 20 2. 5 0. 25 0 90 90 90 1. 25 0. 125 0 20 20 20 0. 625 0. 0625 0 20 20 20 110 201138631 1. 25 0. 25 0 90 90 90 0. 625 0. 125 0 20 20 50* 0. 3125 0. 0625 0 20 20 20 0. 625 0. 25 0 90 90 70 0. 3125 0. 125 0 20 20 20 Table 141 PPMAI A5 Tetraisophthalonitrile A5 Average Death % Tetrachloroisocyanide Expected Control Observed Control 2. 5 0. 0625 0 70 70 70 1. 25 0. 0625 0 70 70 70 0. 625 0. 0625 0 70 70 100* 0. 3125 0. 0625 0 70 70 100* 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 0 0 20* Table 142 A5 PPMAI Ring Block A5 Average Death % Loop Block Expected Control Observed Control 10 0. 25 0 50 50 20 5 0. 25 0 50 50 20 2. 5 0. 25 0 50 50 20 1. 25 0. 25 0 50 50 50 0. 625 0. 25 0 50 50 20 Table 143 PPMAI Average Death % Expected observed A5 Waiting Klein A5 Waiting Klee Control Control 1. 25 0. 03125 0 70 70 70 0. 625 0. 03125 0 70 70 90* 0. 3125 0. 03125 0 70 70 90* 0. 15625 0. 03125 0 70 70 100* 0. 078125 0. 015625 0 0 0 20* 0. 078125 0. 03125 0 70 70 100* 0. 0390625 0. 015625 0 0 0 20* 111 201138631 Table 144 A5 PPMAI Compound m A5 Average Death % Compound III Expected Control Observed Control 10 0. 25 0 70 70 70 5 0. 125 0 20 20 50* 5 0. 25 0 70 70 90* 2. 5 0. 125 0 20 20 50* 2. 5 0. 25 0 70 70 90* 1. 25 0. 125 0 20 20 20 1. 25 0. 25 0 70 70 100* 0. 625 0. 125 0 20 20 50* 0. 3125 0. 0625 0 0 0 20* 0. 625 0. 25 0 70 70 90* 0. 3125 0. 125 0 20 20 50* 0. 15625 0. 0625 0 0 . 0 20* Table 145 A5 PPMAI Compound IV A5 Average Death % Compound IV Expected Control Observed Control 10 0. 25 0 90 90 90 5 0. 125 0 20 20 20 5 0. 25 0 90 90 90 2. 5 0. 125 0 20 20 20 2. 5 0. 25 0 90 90 100* 1. 25 0. 125 0 20 20 90* 0. 625 0. 0625 0 0 0 20* 2. 5 0. 5 0 100 100 90 1. 25 0. 25 0 . 90 90 70 0. 625 0. 125 0 20 20 50* 0. 3125 0. 0625 0 0 0 20* 0. 625 0. 25 0 90 90 70 0. 3125 0. 125 0 20 20 20 Table 146 PPMAI mean death % Expected observed A6 Atomin A6 Atomin Control Control 112 201138631 5 0. 125 0 90 90 90 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 50 50 50 0. 625 0. 015625 0 20 20 20 2. 5 0. 125 0 90 90 90 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 50 50 20 0. 3125 0. 015625 0 20 20 0 1. 25 0. 125 0 90 90 90 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 50 50 20 0. 15625 · 0. 015625 0 20 20 0 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 70 70 70 0. 15625 0. 03125 0 50 50 20 0. 078125 0. 015625 0 20 20 0 0. 3125 0. 125 0 90 90 90 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 50 50 20 0. 0390625 0. 015625 0 20 20 0 Table 147 A6 PPMAI Iso-Pezime A6 Average Death % Iso-Pezami Expected Control Observed Control 20 0. 5 0 90 90 100* 10 0. 25 0 70 70 70 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 10 0. 5 0 90 90 100* 5 0. 25 0 70 70 70 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 5 0. 5 0 90 90 100* 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 50 50 50 113 201138631 0. 3125 0. 0625 0 20 20 20 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 70 70 70 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 Table 148 A6 PPMAI Tetraisophthalonitrile A6 Average Death % Tetrachloroisocyanide Expected Control Observed Control 10 0. 25 0 20 20 20 5 0. 25 0 20 20 20 2. 5 0. 25 0 20 20 20 1. 25 0. 25 0 20 20 20 0. 625 0. 25 0 20 20 20 Table 149 A6 PPMAI Loop Block A6 Average Death % Loop Block Expected Control Observed Control 20 0. 5 0 50 50 70* 10 0. 25 0 20 20 20 20 1 0 70 70 90* 10 0. 5 0 50 50 70* 5 0. 25 0 20 20 20 20 2 0 90 90 90 10 1 0 70 70 90* 5 0. 5 0 50 50 70* 2. 5 0. 25 0 20 20 20 10 2 0 90 90 90 5 1 0 70 70 90* 2. 5 0. 5 0 50 50 70* 1. 25 0. 25 0 20 20 20 5 2 0 90 90 90 2. 5 1 0 70 70 90* 1. 25 0. 5 0 50 50 70* 0. 625 0. 25 0 20 20 20 Table 150____ PPMAI Average Death % I Observed 114 201138631 A6 Waiting for Klee A6 Waiting for Klee Control Control 20 0. 5 0 90 90 90 10 0. 25 0 90 90 90 5 0. 125 0 90 90 90 2. 5 0. 0625 0 70 70 90* 1. 25 0. 03125 0 20 20 50* 20 1 0 90 90 90 10 0. 5 0 90 90 90 5 0. 25 0 90 90 90 2. 5 0. 125 0 90 90 90 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 20 20 20 20 2 0 90 90 90 10 1 0 90 90 90 5 0. 5 0 90 90 90 2. 5 0. 25 0 90 90 90 1. 25 0. 125 0 90 90 90 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 20 20 20 10 2 0 90 90 90 5 1 0 90 90 90 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 90 90 90 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 70 70 70 0. 15625 0. 03125 0 20 20 20 5 2 0 90 90 90 2. 5 1 0 90 90 90 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 90 90 90 0. 3125 0. 125 0 90 90 90 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 20 20 50* 0. 0390625 0. 015625 0 0 0 20* Table 151 PPMAI mean death % Expected observed A6 compound m A6 compound ΓΠ Control Control 115 201138631 20 0. 5 0 90 90 90 10 0. 25 0 70 70 70 5 0. 125 0 20 20 20 10 0. 5 0 90 90 90 5 0. 25 0 70 70 70 2. 5 0. 125 0 20 20 20 5 0. 5 0 90 90 90 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 20 20 50* 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 20 20 20 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 70 70 70 0. 3125 0. 125 0 20 20 20 Table 152 A6 PPM AI Compound IV A6 Average Death % Compound rv Expected Control Observed Control 10 0. 25 0 90 90 90 5 0. 125 0 20 20 20 5 0. 25 0 90 90 90 2. 5 0. 125 0 20 20 20 2. 5 0. 25 0 90 90 90 1. 25 0. 125 0 20 20 20 1. 25 0. 25 0 90 90 90 0. 625 0. 125 0 20 20 20 0. 625 0. 25 0 90 90 90 0. 3125 0. 125 0 20 20 20 Table 153 A8 PPMAI Atomiens Mean Death % A8 Atomomin Expected Control Observed Control 5 0. 125 0 90 90 90 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 50 50 50 0. 625 0. 015625 0 20 20 20 2. 5 0. 125 0 90 90 90 116 201138631 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 50 50 20 1. 25 0. 125 0 90 90 90 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 50 50 20 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 70 70 70 0. 15625 0. 03125 0 50 50 20 0. 3125 0. 125 0 90 90 90 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 50 50 20 0. 0390625 0. 015625 0 20 20 0 Table 154 A8 PPMAI Isopipeza A8 Average death % Iso-Pazami Expected Control Observed Control.   20 0. 5 0 90 90 100* 10 0. 25 0 70 70 70 5 0. 125 0 50 50 50 2. 5 0. 0625 0 20 20 20 10 0. 5 0 90 90 100* 5 0. 25 0 70 70 70 2. 5 0. 125 0 50 50 50 1. 25 0. 0625 0 20 20 20 5 0. 5 0 90 90 100* 2. 5 0. 25 0 70 70 70 1. 25 0. 125 0 50 50 50 0. 625 0. 0625 0 20 20 20 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 70 70 70 0. 625 0. 125 0 50 50 50 0. 3125 0. 0625 0 20 20 20 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 70 70 70 0. 3125 0. 125 0 50 50 50 0. 15625 0. 0625 0 20 20 20 Table 155 PPMAI | Average death % | Observed 117 201138631 A8 Four gas isophthalonitrile A8 Four gas isophthalonitrile Control Control 20 0. 5 0 50 50 70* 10 0. 25 0 0 0 20* 10 0. 5 0 50 50 90* 5 0. 5 0 50 50 90* 2. 5 0. 5 0 50 50 90* 1. 25 0. 25 0 0 0 20* 1. 25 0. 5 0 50 50 70* 0. 625 0. 25 0 0 0 20* Table 156 A8 PPMAI Loop Block A8 Average Death % Loop Block Expected Control Observed Control 20 0. 5 0 50 50 70* 10 0. 25 0 20 20 20 20 1 0 70 70 90* 10 0. 5 0 50 50 50 5 0. 25 0 20 20 20 20 2 0 90 90 90 10 1 0 70 70 90* 5 0. 5 0 50 50 50 2. 5 0. 25 0 20 20 20 10 2 0 90 90 90 5 1 0 70 70 90* 2. 5 0. 5 0 50 50 50 1. 25 0. 25 0 20 20 20 5 2 0 90 90 90 2. 5 1 0 70 70 70 1. 25 0. 5 0 50 50 50 0. 625 0. 25 0 20 20 20 Table 157 A8 PPMAI Waiting for Klee A8 Average Death % to Klee Expected Control Observed Control 20 0. 5 0 90 90 90 10 0. 25 0 90 90 90 5 0. 125 0 90 90 90 118 201138631 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 50 50 50 20 1 0 90 90 90 10 0. 5 0 90 90 90 5 0. 25 0 90 90 90 2. 5 0. 125 0 90 90 90 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 50 50 50 20 2 0 90 90 90 10 1 0 90 90 90 5 0. 5 0 90 90 90 2. 5 0. 25 0 90 90 90 1. 25 0. 125 0 90 90 90 0. 625 0. 0625 0 70 70 70 0. 3125 0. 03125 0 50 50 50 10 2 0 90 90 90 5 1 0 90 90 90 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 90 90 90 0. 625 0. 125 0 90 90 90 0. 3125 0. 0625 0 70 70 70 0. 15625 0. 03125 0 50 50 20 5 2 0 90 90 90 2. 5 1 0 90 90 90 1. 25 0. 5 0 90 90 90 0. 625 0. 25 0 90 90 90 0. 3125 0. 125 0 90 90 90 0. 15625 0. 0625 0 70 70 70 0. 078125 0. 03125 0 50 50 50 Table 158 A8 PPMAI Compound ΙΠ A8 Average Death % Compound m Expected Control Observed Control 20 0. 5 0 90 90 90 10 0. 25 0 50 50 70* 5 0. 125 0 20 20 20 10 0. 5 0 90 90 90 5 0. 25 0 50 50 70* 2. 5 0. 125 0 20 20 20 119 201138631 5 0. 5 0 90 90 90 2. 5 0. 25 0 50 50 70* 1. 25 0. 125 0 20 20 50* 2. 5 0. 5 0 90 90 90 1. 25 0. 25 0 50 50 70* 0. 625 0. 125 0 20 20 20 1. 25 0. 5 0 90 90 70 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 20 20 70 -----------^ Table 159 PPMAI mean death % ----- Expected observed A8 compound IV A8 compound IV control control 10 0. 25 0 90 90 90 5 0. 125 0 20 20 20 5 0. 25 0 90 90 90 2. 5 0. 125 0 20 20 20 2. 5 0. 25 0 90 90 90 1. 25 0. 125 0 20 20 20 1. 25 0. 25 0 90 90 90 0. 625 0. 125 0 20 20 20 0. 625 0. 25 0 90 90 70 0. 3125 0. 125 0 20 20 20 Mycosphaerella arachidis (^3;«·Brown spotted j, brown leaf spot of groundnut: directly mix the fungus from the low temperature storage fungus (Ma Ling f grape ♦ Tang poetry liquid). After putting the test compound (DMSO) solution into the microtiter plate (96_well format), add the nutrient medium containing fungi, and put the test tray at 24 C. The inhibition of growth was determined by culture and at about 5 to 620 nm after application. The application rate was measured spectrophotometer after 6 days. The person shown in the table: 120 201138631 Table 160 PPM AI mean death % Altoatamine A1 expected to be observed Atomic control control 5 0. 125 0 90 90 90 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 50 50 50 2. 5 0. 125 0 90 90 90 1. 25 0. 0625 0 70 70 90* 0. 625 0. 03125 0 50 50 50 0. 625 0. 0625 0 70 70 90* 0. 625 0. 125 0 90 90 100* 0. 3125 0. 0625 0 70 70 90* 0. 15625 0. 03125 0 50 50 70* 0. 078125 0. 015625 0 0 0 50* 0. 0390625 0. 0078125 0 0 0 20* 0. 3125 0. 125 0 90 90 100* 0. 15625 0. 0625 0 70 70 100* 0. 078125 0. 03125 0 50 50 90* 0. 0390625 0. 015625 0 0 0 70* Table 161 PPMAI A1 Iso-Pezime A1 Average Death % Iso-Pazami Expected Control Observed Control 2. 5 0. 0625 0 70 70 70 1. 25 0. 03125 0 20 20 20 1. 25 0. 0625 0 70 70 70 0. 625 0. 03125 0 20 20 20 0. 625 0. 0625 0 70 70 90* 0. 3125 0. 03125 0 20 20 50* 0. 15625 0. 015625 0 0 0 20* 0. 078125 0. 0078125 0 0 0 20* 0. 3125 0. 0625 0 70 70 100* 0. 15625 0. 03125 0 20 20 90* 0. 078125 0. 015625 0 0 0 90* 0. 0390625 0. 0078125 0 0 0 70* 0. 15625 0. 0625 0 70 70 100* 0. 078125 0. 03125 0 20 20 100* 121 201138631 I 0. 0390625 0. 015625 | 0_0 [ 0 | 90* Table 162 A1 PPMAI Tetraisophthalonitrile A1 Average Death % Tetraisophthalonitrile Expected Control Observed Control 10 0. 25 0 50 50 50 5 0. 125 0 20 20 20 5 0. 25 0 50 50 50 2. 5 0. 125 0 20 20 20 2. 5 0. 25 0 50 50 50 1. 25 0. 125 0 20 20 20 1. 25 0. 25 0 50 50 50 0. 625 0. 125 0 20 20 20 0. 625 0. 25 0 50 50 50 0. 3125 0. 125 0 20 20 20 Table 163 A1 PPMAI Loop Block A1 Average Death % Loop Block Expected Control Observed Control 5 0. 125 0 70 70 70 2. 5 0. 125 0 70 70 50 1. 25 0. 125 0 70 70 50 0. 625 0. 125 0 70 70 50 0. 3125 0. 125 0 70 70 50 Table 164 PPMAI Average Death % Expected Observed A1 Waiting for Klee A1 Waiting for Klee Control Control 0. 3125 0. 0078125 0 50 50 50 0. 15625 0. 0078125 0 50 50 50 0. 078125 0. 0078125 0 50 50 100* 0. 0390625 0. 00390625 0 0 0 70* 0. 0390625 0. 0078125 0 50 50 100* Table 165

PPMAI mean death % Expected observed 122 201138631 A1 Compound ΠΙ A1 Compound m Control Control 2.5 0.0625 0 90 90 90 1.25 0.03125 0 20 20 20 0.625 0.015625 0 0 0 20* 1.25 0.0625 0 90 90 90 0.625 0.03125 0 20 20 20 0.3125 0.015625 0 0 0 20* 0.625 0.0625 0 90 90 90 0.3125 0.03125 0 20 20 70* 0.15625 0.015625 0 0 0 20* 0.3125 0.0625 0 90 90 100* 0.15625 0.03125 0 20 20 100* 0.078125 0.015625 0 0 0 100* 0.0390625 0.0078125 0 0 0 90* 0.15625 0.0625 0 90 90 100* 0.078125 0.03125 0 20 20 100* 0.0390625 0.015625 0 0 0 100* Table 166 A1 PPMAI Compound IV A1 Average % of death Compound IV Controlled observed control 5 0.125 0 90 90 70 2.5 0.0625 0 20 20 20 2.5 0.125 0 90 90 70 1.25 0.0625 0 20 20 20 1.25 0.125 0 90 90 70 0.625 0.0625 0 20 20 20 0.625 0.125 0 90 90 70 0.3125 0.125 0 90 90 90 0.15625 0.0625 0 20 20 20 Table 167 A5 PPMAI Atomin A5 Average Death % Atomin is expected to control the observed control 5 0.125 0 90 90 90 2.5 0.0625 0 50 50 70* 1.25 0.03125 0 20 20 20 2.5 0.125 0 90 90 90 123 201138631 1.25 0.0625 0 50 50 70* 0.625 0.03125 0 20 20 20 1.25 0.125 0 90 90 90 0.625 0.0625 0 50 50 70* 0.3125 0.03125 0 20 20 20 0.625 0.125 0 90 90 90 0.3125 0.0625 0 50 50 70* 0.15625 0.03125 0 20 20 20 0.3125 0.125 0 90 90 100* 0.15625 0.0625 0 50 50 70* 0.078125 0.03125 0 20 20 20 Table 168 PPMAI A5 Iso-Pezime A5 Average Death % Iso-Pakimei Expected Control Observation Controls to 2.5 0.0625 0 90 90 90 1.25 0.03125 0 20 20 20 1.25 0.0625 0 90 90 70 0.625 0.03125 0 20 20 20 0.625 0.0625 0 90 90 70 0.3125 0.03125 0 20 20 20 0.3125 0.0625 0 90 90 90 0.15625 0.03125 0 20 20 20 0.15625 0.0625 0 90 90 90 0.078125 0.03125 0 20 20 20 Table 169 A5 PPMAI Tetrachloroisocyan A5 Average death % Four gas isophthalonitrile expected control observed control 20 0.5 0 70 70 100* 10 0.5 0 70 70 100 * 5 0.5 0 70 70 100* 2.5 0.5 0 70 70 100* 1.25 0.25 0 0 0 20* 1.25 0.5 0 70 70 100* 0.625 0.25 0 0 0 20* Table 170 124 201138631 A5 PPMAI Ring Block A5 Average Death % Ring The control is expected to control the control 10 0.25 0 70 70 70 5 0.125 0 20 20 20 5 0.25 0 70 70 70 2.5 0.125 0 20 20 20 2.5 0.25 0 70 70 70 1.25 0.125 0 20 20 20 1.25 0.25 0 70 70 70 0.625 0.125 0 20 20 0 0.625 0.25 0 70 70 70 0.3125 0.125 0 20 20 20 0.15625 0.0625 0 0 0 20* Table 171 PPM AI Average Death % Expected observed A5 Waiting for Klime 5 Waiting for Klee Control 0.625 0.015625 0 50 50 50 0.3125 0.015625 0 50 50 50 . 0.15625 0.0078125 0 0 0 20* 0.15625 0.015625 0 50 50 50 0.078125 0.015625 0 50 50 90* 0.0390625 0.015625 0 50 50 50 Table 172 PPMAI A5 Compound ΠΙ A5 Average % of death Compound m Expected control observed Control 1.25 0.03125 0 70 70 70 0.625 0.03125 0 70 70 70 0.3125 0.03125 0 70 70 70 0.15625 0.03125 0 70 70 90* 0.078125 0.015625 0 0 0 20* 0.15625 0.0625 0 100 100 90 0.078125 0.03125 0 70 70 70 0.0390625 0.015625 0 0 0 20* Table 173 125 201138631 A5 PPM AI Compound IV A5 Average Death % Compound IV Expected Control Observed Control 5 0.125 0 90 90 90 2.5 0.0625 0 50 50 50 2.5 0.125 0 90 90 90 1.25 0.0625 0 50 50 50 1.25 0.125 0 90 90 90 0.625 0.0625 0 50 50 50 0.625 0.125 0 90 90 90 0.3125 0.0625 0 50 50 50 0.3125 0.125 0 90 90 90 0.15625 0.0625 0 50 50 20 Table 174 PPMAI A6 Atomin A6 Mean Death % Atomin is expected to control the observed control 2.5 0.0625 0 90 90 90 1.25 0.03125 0 50 50 50 0.625 0.015625 0 20 20 20 1.25 0.0625 0 90 90 90 0.625 0.03125 0 50 50 50 0.3125 0.015625 0 20 20 20 0.625 0.0625 0 90 • 90 70 0.3125 0.03125 0 50 50 50 0.15625 0.015625 0 20 20 20 0.3125 0.0625 0 90 90 90 0.15625 0.03125 0 50 50 50 0.078125 0.015625 0 20 20 20 0.0390625 0.0078125 0 0 0 0 0.15625 0.0625 0 90 90 90 0.078125 0.03125 0 50 50 50 0.0390625 0.015625 0 20 20 20 Table 175 PPMAI mean death % Expected observed A6 Iso-Pezime A6 异略答J US control control 2.5 0.0625 0 50 50 70 * 126 201138631 1.25 0.0625 0 50 50 70* 0.625 0.03125 0 20 . 20 20 0.625 0.0625 0 50 50 70* 0.3125 0.03125 0 20 20 20 0.3125 0 .0625 0 50 50 70* 0.15625 0.03125 0 20 20 20 0.15625 0.0625 0 50 50 50 0.078125 0.03125 0 20 20 20 Table 176 A6 PPMAI Tetraisophthalonitrile A6 Mean Death % Four gas isophthalonitrile expected to control the observed control 20 0.5 0 100 100 100 10 0.25 0 20 20 20 5 0.25 0 20 20 20 2.5 0.25 0 20 20 20 1.25 0.25 0 20 20 20 0.625 0.25 0 20 20 20 Table 177 A6 PPMAI ring block A6 average death % ring gauze expected Controlled observed control 5 0.125 0 20 20 20 2.5 0.125 0 20 20 20 1.25 0.125 0 20 20 20 1.25 0.25 0 100 100 90 0.625 0.125 0 20 20 20 0.625 0.25 0 100 100 90 0.3125 0.125 0 20 20 20 Table 178 A6 PPMAI Waiting for Klein A6 Average Death % Controlled by Klee Expected Control 0.625 0.015625 0 90 90 70 0.3125 0.0078125 0 20 20 20 0.15625 0.00390625 0 0 0 0 0.3125 0.015625 0 90 90 50 127 201138631 0.15625 0.0078125 0 20 20 20 0.15625 0.015625 0 90 90 100* 0.078125 0.0078125 0 20 20 20 0.078125 0.015625 0 90 90 90 0.0390625 0.0078125 0 20 20 20 0.0390625 0.015625 0 90 90 70 Table 179 PPMAI A6 Compound ΙΠ A6 Average % of death Compound III Controls observed for control 5 0.125 0 90 90 90 2.5 0.0625 0 70 70 70 1.25 0.03125 0 50 50 20 0.625 0.015625 0 20 20 20 2.5 0.125 0 90 90 90 1.25 0.0625 0 70 70 70 0.625 0.03125 0 50 50 20 0.3125 0.015625 0 20 20 20 1.25 0.125 0 90 90 100* 0.625 0.0625 0 70 70 90* 0.3125 0.03125 0 50 50 50 0.15625 0.015625 0 20 20 20 0.625 0.125 0 90 90 100* 0.3125 0.0625 0 70 70 70 0.15625 0.03125 0 50 50 20 0.078125 0.015625 0 20 20 0 0.3125 0.125 0 90 90 100* 0.15625 0.0625 0 70 70 70 0.078125 0.03125 0 50 50 20 0.0390625 0.015625 0 20 20 20 Table 180 A6 PPMAI Compound IV A6 Average Death % Compound IV Controls observed for expected control 5 0.125 0 90 90 90 2.5 0.0625 0 20 20 20 2.5 0.125 0 90 90 90 1.25 0.0625 0 20 20 20 128 201138631 1.25 0.125 0 90 90 90 0.625 0.0625 0 20 20 20 0.625 0.125 0 90 90 90 0.3125 0.0625 0 20 20 50* 0.3125 0.125 0 90 90 90 0.15625 0.0625 0 20 20 20 Table 181 PPMAI A8 Atomin A8 Average death % Tomin is expected to control the observed control. 2.5 0.0625 0 90 90 90 1.25 0.03125 0 70 70 70 0.625 0.015625 0 20 20 20 1.25 0.0625 0 90 90 90 0.625 0.03125 0 70 70 70 0.3125 0.015625 0 20 20 20 0.625 0.0625 0 90 90 90 0.3125 0.03125 0 70 70 50 0.15625 0.015625 0 20 20 20 0.3125 0.0625 0 90 90 90 0.15625 0.03125 0 70 70 50 0.078125 0.015625 0 20 20 20 0.15625 0.0625 0 90 90 90 0.078125 0.03125 0 70 70 50 0.0390625 0.015625 0 20 20 20 Table 182 PPMAI A8 Isopipeza A8 Average death % Iso-Pezami expected control observed observed 2.5 0.0625 0 70 70 70 1.25 0.03125 0 20 20 20 1.25 0.0625 0 70 70 70 0.625 0.03125 0 20 20 20 0.625 0.0625 0 70 70 70 0.3125 0.03125 0 20 20 20 0.3125 0.0625 0 70 70 90* 0.15625 0.03125 0 20 20 20 0.078125 0.015625 0 0 0 20* 129 201138631 0.15625 0.0625 0 70 70 70 0.078125 0.03125 0 20 20 20 Table 183 A8 PPMAI Tetraisophthalonitrile A8 Mean death % Four gas isophthalonitrile expected to control the observed control 20 0.5 0 70 70 90* 10 0.25 0 20 20 20 10 0.5 0 7 0 70 90* 5 0.25 0 20 20 20 5 0.5 0 70 70 100* 2.5 0.25 0 20 20 20 2.5 0.5 0 70 70 100* 1.25 0.25 0 20 20 20 1.25 0.5 0 70 70 70 0.625 0.25 0 20 20 20 Table 184 A8 PPMAI Circumference A8 Average death % Loop control expected to observe control 20 0.5 0 100 100 100 10 0.25 0 100 100 100 5 0.125 0 20 20 20 2.5 0.125 0 20 20 20 1.25 0.125 0 20 20 20 0.625 0.125 0 20 20 20 0.3125 0.125 0 20 20 20 Table 185 PPMAI Average Death % Expected observed A8 Waiting KL A8 Klee Control Control 0.625 0.015625 0 90 90 90 0.3125 0.0078125 0 20 20 20 0.3125 0.015625 0 90 90 100* 0.15625 0.0078125 0 20 20 20 0.15625 0.015625 0 90 90 70 0.078125 0.0078125 0 20 20 20 130 201138631 0.0390625 0.00390625 0 0 0 0 0.078125 0.015625 0 90 90 90 0.0390625 0.0078125 0 20 20 20 0.0390625 0.015625 - 0 90 90 100* Table 186 PPMAI A8 Compound ΠΙ A8 Mean death % Compound 预期 Expected control observed control 2.5 0.0625 0 90 90 70 1.25 0.03125 0 50 50 20 0.625 0.015625 0 20 20 20 1.25 0.0625 0 90 90 70 0.625 0.03125 0 50 50 20 0.3125 0.015625 0 20 20 20 0.625 0.0625 0 90 90 70 0.3125 0.03125 0 50 50 20 0.15625 0.015625 0 20 20 20 0.3125 0.0625 0 90 90 90 0.15625 0.03125 0 50 50 50 0.078125 0.015625 0 20 20 20 0.15625 0.0625 0 90 90 70 0.078125 0.03125 0 50 50 50 0.0390625 0.015625 0 20 20 50* Table 187 A8 PPMAI Compound IV A8 Average death % Compound IV Expected control observed control 5 0.125 0 90 90 90 2.5 0.0625 0 20 20 20 2.5 0.125 0 90 90 90 1.25 0.0625 0 20 20 20 1.25 0.125 0 90 90 90 0.625 0.0625 0 20 20 20 0.625 0.125 0 90 90 90 0.3125 0.0625 0 20 20 20 0.3125 0.125 0 90 90 70 0.15625 0.0625 0 20 20 20 131 201138631 Fusarium oxysporum (Fwsarz'wm cw/morwwj (root rot): The spores of fungi taken from low temperature storage are directly mixed in nutrient medium (potato glucose broth). After the (DMSO) solution of the test compound is placed in a microtiter plate (96-well format), a nutrient solution containing fungal spores is added. The test discs were cultured at 24 ° C and the inhibition of growth was measured with a luminometer 48 hours after the application. The application rates are as shown in the table: Table 188 A1 PPMAI Tetraisophthalonitrile A1 Average death % Four gas isophthalonitrile expected control observed control 20 1 0 20 20 50* 10 1 0 20 20 50* 5 1 0 20 20 50* 2.5 0.5 0 0 0 20* 2.5 1 0 20 20 50* 1.25 0.5 0 0 0 20* Table 189 PPMAI mean death % Expected observed A1 ring A1 ring control control 20 2 0 20 20 20 10 2 0 20 20 20 5 2 0 20 20 20 Table 190 A1 PPMAI to Klee A1 Average death % Controls observed by Klee expectation control 20 0.5 0 20 20 0 10 0.25 0 20 20 0 20 1 0 20 20 20 10 0.5 0 20 20 0 5 0.25 0 20 20 0 132 201138631 20 2 0 90 90 20 10 1 0 20 20 20 5 0.5 0 20 20 0 2.5 0.25 0 .20 20 0 10 2 0 90 90 50 5 1 0 20 20 20 2.5 0.5 0 20 20 0 1.25 0.25 0 20 20 0 5 2 0 90 90 70 2.5 1 0 20 20 20 1.25 0.5 0 20 20 20 0.625 0.25 0 20 20 0 Table 191 A1 PPM AI Compound IV Al Average death % Compound IV Expectation Controlled observed control 20 1 0 20 20 20 20 2 0 50 50 50 10 1 0 20 20 20 10 2 0 50 50 50 5 1 0 20 20 20 5 2 0 50 50 50 2.5 1 0 20 20 20 Table 192 A5 PPMAI Atomin A5 Average Death % Atomin is expected to control the observed control 20 0.5 0 0 0 20* 20 1 0 20 20 20 10 0.5 0 0 0 20* 20 2 0 20 20 20 10 1 0 20 20 20 5 0.5 0 0 0 20* 10 2 0 20 20 20 5 1 0 20 20 20 2.5 0.5 0 0 0 20* 5 2 0 20 20 20 2.5 1 0 20 20 20 133 201138631 1.25 0.5 0 0 〇 20* Table 193 PPM AI Mean Death % Expected observed A5 four-gas isophthalonitrile A5 four-gas isophthalonitrile control control 20 0.5 0 0 0 20* 20 1 0 50 50 90* 10 0.5 0 0 0 20* 10 1 0 50 50 70* 5 0.5 0 0 0 20* 5 1 0 50 50 100* 2.5 0.5 0 0 0 20* 2.5 1 0 50 50 90* 1.25 0.5 0 0 0 20* Table 194 PPMAI mean death % Expected observed A5 Ring Block A5 Ring Holder Control 20 2 0 20 20 20 10 2 0 20 20 20 5 2 0 20 20 20 Table 195 A5 PPM AI Waiting for A5 Average Death % Controlled by Klee Expected Control 20 0.5 0 20 20 20 10 0.25 0 20 20 20 20 1 0 70 70 50 10 0.5 0 20 20 20 5 0.25 0 20 20 20 10 1 0 70 70 50 5 0.5 0 20 20 20 2.5 0.25 0 20 20 20 5 1 0 70 70 70 2 .5 0.5 0 20 20 20 1.25 0.25 0 20 20 20 2.5 1 0 70 70 70 134 201138631 1.25 0.5 0 20 20 20 0.625 0.25 0 20 20 20 Table 196 PPMAI mean death % Expected observed A5 compound IV A5 compound rv control Control 20 1 0 20 20 20 20 2 0 50 50 50 10 1 0 20 20 20 10 2 0 50 50 50 5 1 0 20 20 20 5 2 0 50 50 50 2.5 1 0 20 20 20 Table 197 PPMAI mean death °/ 〇 Expected observed A6 compound IV A6 Compound IV Control control 20 1 0 20 20 20 10 0.5 0 0 0 20* 20 2 0 50 50 50 10 1 0 20 20 20 10 2 0 50 50 50 5 1 0 20 20 20 5 2 0 50 50 50 2.5 1 0 20 20 20 Table 198 PPMAI mean death % A8 compound expected to be observed IV A8 Compound IV Control Control 20 1 0 20 20 20 10 0.5 0 0 0 20* 20 2 0 50 50 50 10 1 0 20 20 20 10 2 0 50 50 50 5 1 0 20 20 20 5 2 0 50 50 50 2.5 1 0 20 20 20 135 201138631 It is not shown that there is no fungal death or one of the compounds and combinations of compounds killed in the test. 1 00% of the data. [Simple diagram description] None [Main component symbol description] None 136

Claims (1)

201138631 VII. Patent application scope: 1. A decontamination mixture comprising component A and component 'B, wherein component A is a compound of formula I Wherein one of Y1 and Y2 is S, SO or S02 and the other is CH2; L is a direct bond or a fluorene group; A1 and A2 are CH, or one of A1 and A2 is CH and the other is N; R1 Hydrogen or mercapto; R2 is chlorodifluoromethyl or trifluoromethyl; 113 is 3,5-dibromo-phenyl, 3,5-di-phenyl-, 3,4-dichloro-phenyl Or 3,4,5-trichloro-phenyl; R4 is an alkyl group; R5 is hydrogen; or R4 and R5 together form a bridged 1,3-butadiene group; and component B is selected from the following Fungicides: strobilurin fungicides, which comprise groups selected from the group consisting of: Azoxystrobin, Dimoxystrobin, Enestrobin ), I.菌I I 137 201138631 (Fluoxastrobin), Kresoxim-methyl, Metominostrobin, 史rysastr〇bin, Picoxystrobin, Bai Kemin ( Pyraclostrobin) and trifloxystrobin; azole fungicides, including those selected from the group consisting of: Azaconazole, Bromuconazole, Cyproconazole, Difenoconazole, Diniconazole, Dakli-M, Epoxiconazole, Fenbuconazole, defeated. Fluquinconazole, Flusilazole, Flutriafol, Hexaconazole, Imazalil, Imibenconazole, lpConaz〇le, chlorpyrifos Metconazole, Myclobutanil, Oxpoconazole, Pefurazoate, Penconazole, prochl〇raz, Propiconon, Prothi 〇conazole), Simeconazole, Tebuconazole, Tetraconazole, Triadimefon, Triadimenol, Triflumizole 'Triticonazole, Diclobutrazole, Etaconazole, Furconazole, cis-fuconazole, Thiabendazole and quinconazole; phenylpyrrole fungicides, The inclusions are selected from the group consisting of: 138 201138631 Seed dressings of Fenpiclonil and Fludioxonil; anilino-pyrimidine fungicides comprising groups selected from the group consisting of: Cyprodinil, Mepanipyrim, and Pyrimethanil; Morpholine fungicides, which comprise groups selected from the group consisting of: Aldimorph, Dodemorph ), Fenpropimorph, Tridemorph, Fenpropidin, and Spiroxamine; the methotrexate fungicides, which comprise the same group selected from the group consisting of Isopyrazam, Sedaxane, Bixafen, penthi〇pyrad, Fluxapyroxad, Boscalid, penflufen ), fluoropyridylamine (Fluopyram), compound of formula II Compound of formula III 139 (III), 201138631 and formula ιν a carboxylic acid amide amine fungicide comprising the group selected from the group consisting of: M andipr op ami d, Benthiavalicarb, Dimethomorph; Chlorothalonil, Fluazinam, Dithianon, Metrafenone, Tricyclazole, Mefenoxam, Metalaxyl , Acibenz〇lar, Mancozeb, Amet〇ctradine, and Cyflufenamid. 2. The abatement mixture according to the scope of the patent application, wherein in the compound of formula I, L is a direct bond or an anthracene group; one of γι and γ2 is S and the other is CH2; Αι and 八二系CH R1 is hydrogen or methyl; r2 is difluoroindenyl; R3 is 3,5_digas-phenyl; r4 is methyl; and r5 is hydrogen. 3. The abatement mixture according to the scope of the patent application, wherein in the compound of formula I, L is a direct bond or an anthracene group; one of γ| and γ is S〇 and the other is CH2; Αι and Α2 CH ; Ri is hydrogen or methyl; R 2 is trimethyl; R 3 is 3,5 · dih. phenyl; r 4 is methyl; and 5 is 140 201138631 hydrogen. 4. According to the patent application Fan Yuandi s〇 苐 苐 苐 苐 苐 苐 , , , , , , , , , , 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 5. According to the pesticidal mixture of the scope of the patent application, in the compound 1 'L series direct bond or methylene; one of Y1 and Y2 is S02 and the other is CH2; A丨 and A2 Ntr « 2 Λ and A system CH; R1 is hydrogen or methyl; R2 is trifluoromethyl; R3 is 3 5_ - preparation ^ # 4 5 v 》1 gas-based; R4 is methyl; and R5 is hydrogen 0 6. According to the ninth aspect of the patent scope, the quarantine of the stagnation of sigma, where γ2 is CIi2 and γ1 is s, s〇 or S〇2, and wherein L is methylene , γ2 is s, guilty or γι is CH2. 7. The decontamination mixture according to any one of claims 6 to 6, wherein the component A is a mixture of the compound of the formula I* and the compound of the formula 141 201138631 Where the i** compound of Mohr is more than 50% than the dry phase of the mixture. The abatement mixture according to any one of claims 1 to 7, wherein the component lanthanum is selected from the group consisting of: a Stoby-type fungicide selected from the group consisting of: Atomin's two Mostobi, enestrobin, fluoxastrobin, kexinxin, oxycide, sputum Φ^ 史史托 negative, oxypoxystrobin, kekemin and trifluoro-sensitive; The azole fungicide' is selected from the group consisting of: Azacon saliva, Mok, Zuo Ke, Klitak, Dayi θ, Fink, fluoroquinazole, ankle Get, protect the fen, Fickley dying, easy amine seat, germs saliva, extant, McKinney, evil ° meters. Sitting, draping, Pingyi Temple, her Α h Ten seeing Poker La, Puckley, Purcelle, Shi Xidun, Dekli, Quartet __ brother and two Thai points, three Tailong, Saifu, Sterolazole, dilobutazole, and sputum. Sit; B (four) " Sit 'Sci-fi bacteria. Sitting, rot m each fungicide, which is selected from the group consisting of: seed dressing ° and protection of Ning; anilino-pyridinium fungicidal group Danshen W is selected from the group consisting of the following, Defensin and pyrimethanil; morphine fungicide-free sputum, the agent is selected from the group consisting of: Adi Mo, diuron, fenflurazine - bacteriocin; Spiral methotrexate fungicides, which are selected from the group consisting of: 142 201138631 Iso-Pezime, Sedan, Baikefen, Nitrofloxacin, Fluoride, Baikli, Pentafluoro Fen, flupirtine, compound of formula II Compound of formula III And a compound of formula IV a carboxylic acid amide amine fungicide selected from the group consisting of: dipyridinamide, benzilid, daxen; tetrachloroisophthalonitrile, chlorpromazine, nitrile thiopurine, fentanyl , trimethoprim, dextromethorphan, chlordane, arsenic benzene, zinc manganese nitrite, emmetatin, and cycloflufenamide. 9. The decontamination compound 143 201138631 according to any one of claims 1 to 7, wherein the component B is selected from the group consisting of the following compounds: the azotophene Benzonitrile, cyclamate, chlorfluazene, diacetyl-profenil s, halal, sedative, sedative, arsenic, benzene, sulphate, sip, pingke, puqin, zinc zhongpu , thiophene bacteria. Sitting, Bai Kemin, Bai Keli, Bai Kefen, fluorine.比 醯 吼嗔, 吼嗔 胺, 腐 ' 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶 扶Xin-thiol, phenothiamine, dadeclofen, a compound of the formula π, a compound of the formula ηι and a compound of the formula 1. 10. The abatement mixture according to any one of the claims of the scope of the invention, wherein the component B is selected from the group consisting of: atropine, isopizami 'four gas isophthalonitrile, ring glu , Klein 'bis-propargylamine, dextromethorphan, chlordane, sedative, arsenic benzene, zinc sulphate I Mengnipu, thiophene t» sit, nin, siplo, pingke , chloroprene baikemin, baike, baikefen, fluopyram, pirfenamide, rot, compound of formula III and compound of formula Iv. η·According to the scope of patents in the middle! ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ ～ Bismuthamide, dextromethorphan, chlordane, sedative, arsenic benzene, trophic, rot, compound of formula III and compound of formula ν. The compound according to any one of items 1 to 7 which is a mixture of the following components: sub-12. According to the patent application range, wherein the component lanthanide is selected from the group consisting of tomin, iso(tetra), tetraisophthalonitrile , cycloheximide, holly, diclofenac, dextromethorphan, a compound of formula m and a compound of formula IV. 144 201138631 to 12, in addition to any of the above-mentioned acceptable carriers and on-demand. 13. The scope of the application for the j-th mixture, the mixture including agricultural surfactants. 1 *+ · very popular — ^ T Shiyi J Bei·^ κ于: Temple Mixture, where Α Α | | | μ, Xuan Xuan Li ratio is 1 000:1 to 1:1 〇〇〇. I5. A method for controlling plant pathogenic diseases on useful plants or on propagation materials for cooking utensils. The sentence material Gutian 1 includes the application of component A and β t & yv to useful plants, their locations or their propagation materials. ^ W 夂B combination, in which components VIII and B are as defined in paragraphs 1 to 诮 of the scope of the patent application. A month of the 16th, a species of insects, mites, nematodes, and scorpions, and the methods of scorpion animals, their ten harmful organisms, the possession of treasures, the invasion of alpha, the location of m ^ biology, or The combination that is subject to the harmful and vivid application of the component AAB is as defined in the application for the main trial, ^ Knife and J 17: No. 1 to 14 of the patent scope. Seeds comprising a pesticidal mixture as claimed in any of the patents T. The cup-in-the-counter method comprises coating the seed with a mixture as defined in the scope of claims 帛1 to 。. Eight, schema: None 145